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Acute and subacute diseases causing intrinsic spinal cord damage are 
confusing and poorly defined clinically and pathologically. 
of this study is: 
The purpose 
1. To analyse the spectrum of conditions responsible for acute and 
subacute myelopathy in South Africa. 
2. To categorise the clinical presentations and prognosis of the 
illnesses and to correlate these with aetiology. 
3. To assess the validity of diagnostic criteria for acute and subacute 
myelopathy in general and for the different aetiological groups. 
4. To review the literature and to correlate previous studies with the 
present one. 
Thirty-four patients fulfilling strict criteria nave been identified 
over a seven and a half year period using the Groote Schuur Hospital computer 
retrieval system. Although the study was essentially retrospective, 11 of 
these patients were seen personally during their acute illnesses. All these 
patients have suffered from illnesses causing spinal cord dysfunction in the 
absence of trauma, physical agents or any extrinsic presssure such as might 
be caused by tumours or spondylosis. 
than 8 weeks. 
Maximum disability was reached in less 
In 17 patients no cause was identified. The clinical features, 
laboratory findings and courses have been analysed. Among the results, a 
high percentage of patients with Brown-Sequard Syndromes were found with 
possible significance for the pathogenesis of the illness. 
iv 
Seven patients with meningovascular syphilis were analysed as well as 2 
additional patients with spinal cord syphilis not fulfilling the strict 
criteria of the study. Although well known before the penicillin era, this 
entity is not well described in modern neurological literature. Four 
patients had myelopathy associated with pulmonary tuberculosis in the absence 
of tuberculous meningitis or spinal disease. Three of these 4 patients also 
developed optic neuropathy. The association of these conditions has 
previously been described in only 
Epstein-Barr virus infections and 
a very few patients. 
1 had an infection 
Two patients had 
with Mycoplasma 
pneumoniae. Two had systemic lupus erythematosus and 1 had an acute cord 
infarct following an aortic aneurysm repair. 
The literature is reviewed and the findings of this study correlated 
with previous ones. Conclusions regarding termin.9logy, criteria for 
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1. INTRODUCTION 
Acute intrinsic spinal cord disease has been recognised since last 
century. Before the introduction of antibiotics and ventilatory support the 
condition was considered to be fatal(lOl) and thus early literature before 
1950 consists chiefly of reports of pathological findings.C
73 ,SZ,llZ) More 
recently the prognosis has improved significantly and present literature 
deals with the clinical features of the condition often with little patho-
logical correlation. 
The better known condition of acute inflammatory polyradiculoneuropathy 
(Guillain-Barre syndrome) provides some peripheral nervous system parallels 
with acute myelopathy and has been far more extensively studied.(
37 ) In 
contrast myelopathies have been less vigorqusly analysed. Idiopathic 
myelopathies are usually dealt with separately from those with known 
aetiology and it is difficult to delineate the spectrum of the syndrome from 
the literature. 
1.1. Aims 
The aims of this study are: 
1. To analyse the spectrum of conditions responsible for acute and sub-
acute myelopathy in South Africa. 
2. To categorise the clinical presentations, course and prognosis of 
the illnesses and to correlate these with aetiology. 
3. To assess the validity of diagnostic criteria for acute and sub-
acute myelopathy in general and for the different aetiological groups. 
1. 
4. To review the literature and to correlate previous studies with the 
present one. 
1.2. Terminology 
The terminology of acute spinal cord disease is confusing. The most 
commonly used term, "transverse myelitis" implies an inflammatory lesion 
involving both sides of the cord over only a few segments. However, as will 
be seen, none of these features occur in every case. The term "ascending 
myelitis" overcomes one difficulty in describing a disease which progresses 
rostrally to involve many segments longitudinally.(
124 ) However the two 
terms only denote the geographical localisation and do not add to the 
clinico-pathological understanding of the illness. "Myelopathy" is a better 
term than "myelitis" as many acute cord lesions are not inflammatory. 
In this study the terms "acute and subacute myelQpathy" have been used 
exclusively to avoid some of the incorrect connotations of other terminology. 
Just as "peripheral neuropathy" has largely replaced "peripheral neuritis", 
so the same change should be made for a clearer understanding of cord 
disease. 
1.3. Diagnostic Criteria 
It is only in the last 30 years that series of clinically diagnosed 
cases, the majority of whom have survived, have been reported. In order to 
compare the results of such studies, it is necessary to give careful 
attention to the diagnostic criteria used. 
Paine and Byers
120 (1953) described 25 cases of transverse myelopathy in 
children. They did not list any criteria on which the diagnosis was based 
other than the exclusion of cases with concommitant encephalitis. In 1963 
2. 
Altrocchi( 7) described 67 cases of transverse myelopathy. For the first time 
certain criteria for diagnosis were laid down. The condition had to develop 
acutely with intramedullary spinal cord dysfunction not progressing beyond 8 
weeks. It could be ascending or static, usually involving both sides of the 
spinal cord transversely. There should be no previous history of neurological 
symptoms. Direct trauma, extramedullary compresssion, intramedullary 
tumours, radiation myelopathy and combinations of spinal cord and cerebral 
symptoms were excluded. 
the 67 patients. 
However, myelograms were performed in only 25 of 
These criteria, in many ways arbitrary, have dominated later studies. 
Lipton and Teasdall (1973) (lOl) described 34 adults with acutely developing 
"paralysis of at least both lower extremities, : bilateral sensory loss and 
urinary and faecal retention". Patients with antecendent neurologic and 
underlying systemic disease were excluded as were all patients with an 
obvious cause such as herpes zoster, syphilis, trauma or irradiation. In 
spite of these rigid criteria to obtain a standard clinical picture, 3 
different pathologies were found in 6 patients who underwent post-mortem 
examination (infarction, necrotising myelitis and intramedullary capillary 
telangiecetasis). 
Ropper and Poskanzer (1978)(l
3l) reviewing 52 patients emphasised the 
importance of a negative myelogram. Their patients progressed over a maximum 
of 4 weeks, had no antecedent neurological illness and were required to have 
extensive bilateral spinal cord dysfunction with a well defined upper level. 
In 2 cases coming to autopsy, different pathology was seen - one a 
necrotising myelopathy without inflammation and the other demyelination and 
necrosis with profuse inflammation. 
3. 
In an epidemiologic Israeli study, Berman et al. (1981)(
18
) used as 
criteria an acutely developing paraparesis without progression affecting 
motor and sensory systems and sphincters, a clear segmental sensory level 
(excluding Brown-Sequard syndromes) and exclusion of spinal cord compression 
or any known neurological disease including syphilis and encephalitis. 
However, viral illnesses such as zoster were included. 
Bahemuka (1982)(l3 ) studied 23 case in Kenya. His diagnostic 
requirements were no previous neurological illnesses, "fairly rapid 
progression", flaccid or spastic paraplegia with a spinal cord sensory level, 
no encephalitis and a normal myelogram. 
A review of these studies suggests careful attempts to describe a 
standard clinical picture. However the pathology of acute myelopathy is far 
from homogenous and, even when the strictest clinical criteria ar.e laid down, 
the pathology differs. While criteria for acute myelopathy such as 
progression only over a specific time period and negative myelography are 
necessary almost by definition, other criteria seem arbitrary and 
restricting. 
An acute myelopathy involving predominantly half the spinal cord may 
have similar pathology to transverse myelopathy and exclusion of these cases 
may give a distorted view of the spectrum of the condition. Similarly, it is 
illogical to include patients who subsequent to acute myelopathy develop 
optic neuropathy but to exclude those in which optic neuropathy occurs first. 
Pathological studies have shown that patients with acute disseminated 
encephalomyelitis( 2) may have similar cord pathology to certain patients 
with acute myelopathy alone. Thus to exclude all patients with evidence of 
disease above the foramen magnum artificially narrows the disease spectrum. 
4. 
One of the purposes of this study is to describe a wider 
spectrum of 




and was involved in the care of 11 of these patients during the acute phase 
of their illness. The patients' records were analysed and their later course 
assessed by personal follow-up examinations, telephonic communication and 
perusal of hospital records. 
Two additional patients with spinal neurosyphilis who did not fulfill 
the above criteria (1 with an abnormal rnyelogram and 1 with a chronic 
history) are also described separately. 
7. 
2. PATIENTS AND METHODS 
The Groote Schuur Hospital computerised record system was used to
 
identify all patients with acute or subacute spinal cord disease admitted
 
between January 1977 and June 1984. 
Those patients fulfilling the following criteria were included in the 
study: 
(1) Definite clinical evidence of a myelopathy as shown by upper motor 
neurone type weakness of the legs with increased tone and brisk tendon
 
reflexes and/or a definite sensory level usually on the trunk. In the case
 
of those patients with flaccid areflexic paraplegia ("spinal shock"), a 
sensory level was considered essential. 
(2) Progression of the disease to a maximum disability in less than 8 weeks. 
(3) Either (a) a normal myelogram or 
(b) a myelogram showing cord swelling over more than 10 segments or 
(c) in the absence of a myelogram, complete clinical recovery or 
(d) in the absence of a myelogram, an obvious aetiology such as 
meningovascular syphilis. 
(These criteria excluded all cases of myelopathy associated with cervical 
spondylosis, arachnoiditis and compressive lesions). 
(4) An absence of direct trauma or physical agents such as radiotherapy. 
(5) No prior diagnosis of multiple sclerosis according to standard
 
. . ( 126) 
cn.teria. 
Thirty-four patients fulfilling these criteria were identified. 
Although this was essentially a retrospective study, I personally examined 
6. 
3. GENERAL RESULTS 
A few general results are given below. Because of the aetiological 
heterogeneity of the group, the results are analysed in detail later under 
each category: 
(1) Idiopathic Myelopathy. 
17 patients 
(2) Meningovascular Syphilis of the Spinal Cord. 
7 patients 
(3) Myelopathy associated with Pulmonary Tuberculosis (PTB). 
4 patients 
(4) Myelopathy associated with other specific infections. 
3 patients 
(5) Systemic Lupus Erythematosus (SLE) - related myelopathy. 
2 patients 
(6) Spinal Cord Infarction. 
1 patient 
In each category, selected case reports with comments are presented 
first, followed by an analysis of the results and thereafter discussion. 
Owing to the fact that Groote Schuur Hospital has few paediatric beds, 
all patients are over the age of 13 years. Eleven patients were white, 19 
coloured and 4 black. Cape Town, with a large coloured and relatively 
smaller black population, is not representative demographically of South 
Africa as a whole and thus extrapolations from these figures should be made 
with caution. 
Of the 34 patients, 29 had normal myelograms. Four did not have 
myelograms, 2 because complete recovery occurred and 2 because the diagnosis 
8. 
was clinically obvious (1 with serological evidence of neurosyphilis and 1 
with a spinal cord infarct following aortic aneurysm surgery). One patient 
showed cord swelling from the 2nd cervical to the 9th thoracic segment on 
myelogram. 
In view of certain previous studies having excluded patients with 
preceding or concommitant neurological disease localised elsewhere than in 
the spinal cord, such cases that are included in the present study are 
briefly discussed. In only 3 patients was there preceding neurologic 
disease. One patient with neurosyphilis had had a preceding midbrain 
syndrome and 2 patients with neuromyelitis optica associated 
tuberculosis had developed optic neuropathy before the myelopathy. 
with 
In 5 patients the myelopathy was associated: with concommitant neurologic 
disease. One patient with idiopathic myelopathy had extensive brainstem 
involvement and another patient in this group had bilateral facial weakness. 
One patient with SLE-related myelopathy had transient bulbar weakness. One 
patient with mycoplasma associated myelopathy had mild bulbar weakness and 
one seizure and one patient with infectious mononucleosis associated 
myelopathy had a demyelinating peripheral neuropathy. 
9. 
4. IDIOPATHIC MYELOPATHY 
4.1 Case Reports 
Four case reports selected from 17 patients are described. 
Case No. 1. 
A 62 year old previously well white male developed left iliac fossa pain 
in February 1983. Three days later the pain spread from the midline around 
the left flank to the spine and he noticed skin sensitivity in a band over 
the 9th left thoracic dermatone. This lasted 5 days and resolved. The 
following day (day 10 of his illness) he noticed numbness of his right leg 
and 24 hours later weakness of his left leg with difficulty initiating 
micturition and defaecation. By day 13 his left leg was completely paralysed 
and urinary retention necessitated catheterisation. 
Abnormal physical findings was limited to the legs. The left leg was 
flaccid, areflexic and completely paralysed. The right leg was slightly weak 
(grade 3-4/5 power).C 5) There was a sensory level below which pain and touch 
sensation were absent at the 8th right thoracic dermatome (T8). Position 
sense was normal. Anal tone was reduced. By day 16 his condition had 
progressed to a complete bilateral flaccid areflexic paralysis with a sensory 
level for all modalities at T8 bilaterally. 
Cerebrospinal fluid (CSF) examination on day 14 showed a protein 
concentration of 0.9 g/1, 2 + globulin , -3 10 lymphocytes mm and a normal 
glucose concentration. A repeat lumbar puncture 10 days later showed a 
protein concentration of 1,4 g/1, a trace of globulin, 25 lymphocytes, 1 
neutrophil -3 mm and a normal glucose concentration. Stains for fungi and 
bacteria were negative. No viruses were cultured and there was no 
significant rise in viral antibodies, specifically to herpes zoster. 
Syphilitic serology was negative. 
10. 
A myelogram was normal. All serum immunological tests for specific 
organisms and auto-antibodies were negative. The erythrocyte sedimentation 
rate (ESR) was 27 mm in the first hour and the white cell count was normal. 
Acyclovir was administered intravenously for 5 days. The course was 
complicated by urinary tract infection, pressure sores and severe depression. 
Power and sensation did not return, but he slowly developed hypertonia and 
hyperreflexia. He died 7 months after onset of his illness in another 
hospital from undetermined cause. 
Comment 
This patient illustrates the progression of a myelopathy transversely 
across the spinal cord, commencing with root pain and progressing through a 
., 
Brown-Sequard syndrome to a complete myelopathy with initial spinal cord 
shock. In spite of the lack of skin lesions, herpes zoster was considered as 
a possible cause because of the mode of onset, and acyclovir was administered 
with no response. 
Case No. 2 
A previously well · 43 year old coloured male developed mid-thoracic 
backache in July 1981. One week later he developed a cold sensation in his 
right leg which worsened until admission on the 14th day of his illness. He 
developed urgency incontinence and constipation. 
On examination cranial nerves and arms were normal and there was no 
spinal tenderness. Tone was increased in the left leg with power reduced to 
grade 1-2/5. Power in the right leg was minimally reduced (grade 4-5/5). 
There was a sensory level at TS on the right below which touch, pain, 
temperature and vibration sense were absent. 
bilaterally. 
11. 
Position sense was normal 
CSF examination of day 17 showed a protein concentration of 0.5 g/1, no 
-3 globulin, 11 neutrophils and 36 lymphocytes mm 
showed a protein concentration of 0,2 g/1 and 30 
A repeat study 9 days later 
-3 lymphocytes mm . Glucose 
concentration was normal. Culture for bacteria, fungi and viruses was 
negative as was syphilitic serology. 
Myelography was normal. Serum immunologic tests for infective organisms 
and auto-antibodies were negative. 
the white cell count was normal. 
The ESR was 5 mm in the first hour and 
No specific treatment was given. By 3 months after onset, power was 
improved and bladder function and sensation normal. 
returned to work and complained only of constipation. 
By 8 months he had 
The only abnormal 
signs were slight weakness of ankle dorsiflexion bilaterally and leg hyper-
tonia and hyperreflexia. 
Comment 
This patient illustrates the onset of a myelopathy heralded by backache. 
The picture remained that of a Brown-Sequard syndrome with sparing of 
position sense. 
signs. 
Case No. 3 
Fair recovery occurred with residual upper motor neurone 
A 33 year old previously well black male developed a 7 day febrile 
illness with cough and sore throat in October 1983. Two days after it 
resolved, he developed weakness and numbness of both legs. Over 7 days this 
progressed to a complete paraplegia with urinary retention needing 
catheterisation. 
12. 
On examination, cranial nerves and arms were normal. There was a 
complete areflexic flaccid paraplegia with a T8 sensory level below which all 
sensation including position sense was lost. 
sphincter. 
He had a flaccid anal 
CSF examination one day after onset showed a protein concentration of 
0,2 g/1, 
-3 -3 
no globulin, 16 lymphocytes mm and 13 neutrophils mm A repeat 
study 2 weeks later showed a protein concentration of 0,7 g/1, 2 + globulin, 
245 
-3 -3 lymphocytes mm and 60 neutrophils mm A third study 2 months after 
onset showed a protein concentration of 3,0 g/1, 1 + globulin and 23 
lymphocytes 
-3 mm Glucose concentration was normal in all 3 specimens. 
Culture for bacteria, fungi and viruses were negative, as was syphilitic 
serology. 
A myelogram was normal. All serum immunological tests for infective 
agents and auto-antibodies were negative. 
hour and the white cell count was normal. 
The ESR was 40 mm in the first 
No specific treatment was given. His course was complicated by urinary 
infection and pressure sores. He remained completely paraplegic and when 
examined 10 months after onset still had flaccid areflexic legs. Electro-
myography (EMG) 2 months after onset showed positive sharp waves and 
fibrillations in quadriceps, tibialis anterior and extensor hallucis brevis 
bilaterally. 
Comment 
This patient illustrates the onset of an acute myelopathy following a 
non-specific upper respiratory infection. The patient remained areflexic and 
flaccid with an EMG suggesting extensive denervation. Thus he appears to 
have had a longitudinal myelopathy with extensive damage at all levels below 
13. 
TS. Of interest is the rise in CSF protein concentration 2 months after 
onset. 
Case No. 4 
A previously well 22 year old white female developed decreased 
perception of pain in her right leg in April 1984. The next day weakness 
developed in her left leg and that evening she began vomiting. On day 3 of 
her illness drowsiness developed and by day 5 her left leg was so weak she 
could not walk. On day 7 her speech became slurred, she noticed diplopia and 
oscillopsia and her left hand became weak. The next day the right side of 
her face became numb and she noticed loss of taste. On day 13 she developed 
urinary retention. A myelogram was performed, which was normal and she was 
transferred to Groote Schuur Hospital. 
On examination on day 14 she was drowsy but orientated. There was 
bilateral ptosis. Horizontal nystagmus was induced on looking to the right 
and vertical nystagmus on elevating the eyes. Fundi and pupils were normal 
and eye movements full. There was decreased sensation over the right side of 
the face and taste was diminished over the anterior two-thirds of the right 
side of the tongue. There was bilateral lower motor neurone type facial 
weakness. Sensation was diminished on the right side of the pharynx and 
there was bilateral pharyngeal weakness. The tongue was weak bilaterally but 
not fasciculating. 
There was a hypertonic, hyperreflexic weakness of the left arm (grade 3-
5/5) and the left leg (grade 0-2 /5). Power on the right was normal except 
for mild weakness of the leg. Tendon reflexes on the right were also brisk 
and both plantar responses were extensor. There was a sensory level at T4 on 
the right below which touch, pain and temperature were absent. There was 
14. 
decreased position sense in the left foot and decreased vibration sense in 
both ankles and the left hand. 
CSF examination on day 14 showed a protein concentration of 0.45 g/1, no 
-3 4 lymphocytes mm and normal glucose concentration. The CSF IgG globulin, 
quotient 
(100) was suggestive of local IgG synthesis as well as blood-CSF 
barrier impairment. Viral studies were negative. Blood immunological tests 
for infections or auto-immune illnesses were negative. An electro-
encephalogram (EEG) showed diffuse theta activity. 
By day 21 both legs and the left arm were completely paralysed and she 
had become increasingly drowsy. Bulbar functions decreased and respiratory 
difficulties necessitated tracheostomy and supportive ventilation. 
of acyclovir was administered and thereafter cort~costeroids. 
A course 
On day 24 recovery commenced and she was weaned from the ventilator one 
month after admission. By day 52 she was mentally normal. Cranial nerves 
were normal except for mild bilateral facial weakness and a partial left 12th 
cranial nerve palsy. Power in both arms was grade 4-5/5, in the right leg 
3/5 and the left leg 2/5. There was mild spasticity in the legs with hyper-
reflexia. Apart from decreased position sense in the left foot, sensation 
was normal. 
Comment 
This case illustrates the simultaneous development of an acute 
myelopathy and acute brainstem disturbance, and belongs in the spectrum of 
acute disseminated encephalomyelitis.<
106 ) The evidence for myelopathy is 
the Brown-Sequard nature of the signs on admission with a clear unilateral 
thoracic sensory level for pain and temperature and contralateral weakness 
and position sense loss. Midbrain, pons and medulla were involved and this 
15. 
aspect of the 
encephalitis.Cl9 ) 
illness was similar to Bickerstaff's brainstem 
As in Bickerstaff's series, the patient made a remarkable 
recovery suggesting that the major pathology was demyelination rather than 
necrosis. 
4.2. Results 
4.2.1 ~ Sex and Race 
The mean age at onset was 36 years (range 16-62 years). There was no 
sex predominance (8 male, 9 female). 
and 1 was black. 
Six patients were white, 10 coloured 
4.2.2 Preceding illness 
Four patients (24%) had preceding infectious illnesses (3 upper 
respiratory infection, 1 fever, malaise and arthralgia). One patient had 
antecedent minor back strain and 1 had undergone a hysterectomy 6 weeks 
before. Eleven patients (54%) had no antecedent events. There was no 
seasonal preponderance. 
4.2.3 Onset 
In 6 patients (35%) senso~y symptoms were the initial complaint 
numbness, paraesthesiae or temperature disturbance. In 7 patients (41%) pain 
occurred first 
distribution. 
3 with backache and 4 with radicular pains in a thoracic 
In 1 patient (6%) weakness occurred first and in 1 sphincter 
disturbance. In 2 patients combinations of symptoms started simultaneously -
1 motor and sensory and 1 motor, sensory and sphincter disturbance. 
4 . 2.4 Initial course 
Patients were divided into 3 groups according to the course of the 
16. 
disease (classification of Ropper and Pozkanser).(l
3l) Ten patients (59%) 
followed a smoothly progressive course to maximum disability. Six patients 
(35%) followed a stuttering course with the illness stabilising before a new 
symptom developed. One patient (6%) followed a hyperacute course with 
maximum disability in less than 1 hour. 
The following table shows the time from onset to maximum disability: 
Time Patients 
Less than 1 hour 1 
1 - 12 hours 0 
12 - 24 hours 1 
1 - 2 days 1 
2 - 7 days 3 
8 14 days 4 
2 - 3 weeks 4 
3 - 4 weeks 1 
4 - 5 weeks 0 
5 - 6 weeks 2 
4.2.5 Symptoms and signs 
Fever occurred in 6 patients (35%), 2 of whom had secondary infections 
(1 urinary, 1 pneumonic). 
None had neck stiffness. 
Spinal tenderness was present in only 1 patient. 
Pain was a feature of some stage of the illness in 10 patients (59%). 
Five had backache alone, 3 radicular pain alone and 2 both. 
Weakness occurred in all 17 patients. In 5 patients (29%) a flaccid 
paraplegia with areflexia ("cord shock") developed. In 12 patients (71%) 
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increased tone and brisk reflexes were present from the start. Of these 12, 
7 had grade 3-4/5 power in the legs,( 5) 3 had grade 1-2/5 power in at least 1 
leg and 2 had complete paraplegia. In 5 of the 17 patients, arm weakness 
also occurred in spite of a clear thoracic sensory level. 
patients showed some brainstem involvement. 
Two of the 5 
In all 17 patients sensory loss occurred in the legs. In all 17 
disturbance of pain and temperature sensation was found and in 9 position 
sense was also disturbed. In 2 patients sensation was abnormal in the hands 
although there was a clear thoracic sensory level. 
A notable feature was the high proportion of Brown-Sequard syndromes. In 
5 patients either the motor signs were purely unilateral or grossly 
asymmetrical with spinothalamic sensory loss confined to the contralateral 
side. In 2 of these 5 patients position sense was lost, 1 on the same side 
as the motor disability and 1 bilaterally. In 1 patient the sensory signs 
were suggestive of unilateral cord disease (spinothalamic and posterior 
column loss in opposite legs) although the motor signs were bilaterally 
symmetrical. In 1 patient (case No 1) the illness started as a Brown-
Sequard syndrome and progressed to a complete transverse lesion. In another 
patient (case No 4) an initial Brown-Sequard syndrome progressed to complete 
paralysis with the sensory findings remaining dissociated. Thus 8 patients 
(47%) at some stage of the illness showed evidence of predominantly 
unilateral cord involvement. 
Sphincter disturbance occurred in 13 patients (76%). All these had 
urinary problems with 9 having retention needing catheterisation, 1 
developing only loss of bladder sensation and 1 urgency only. Nine of these 







4.2.6 Sensory level 
All 17 patients had clear spinal cord segmental sensory levels for pain, 
although 5 patients had mild arm weakness above the sensory level. The 
levels are shown in the following chart. 
D D D 
cs T1 Tz T3 T4 T5 T6 T7 Ts T9 TlQ Tn T12 11 
4.2.7. Laboratory Results 
Myelograms were normal in 15 patients. In 2 patients myelograms were 
not performed, 
treatment. 
but both made a complete recovery without specific 
CSF was examined in all 17 patients. In 12 patients the CSF ·protein 
concentration was normal, in 5 patients it was raised on at least 1 occasion 
(range 0,5-3,0 g/1). A pleocytosis was found in 10 patients on at least one 
occasion (range 7-305 cells, all but 1 under 50 cells). In all 10, 
lymphocytes predominated. In 7 patients CSF was completely normal. 
Repeat lumbar punctures were performed on 6 patients. In 3 patients, 
the CSF protein concentration rose - in the first patient from 0,9 g/1 2 
weeks after onset to 1,4 g/1 over 10 days; in the second from 0,6 g/1 3 weeks 
after onset to 4,0 g/1 over 14 days and in the third from 0,2 g/1 1 day after 
onset to 0,7 g/1 after 2 weeks and then to 3,0 g/1 after another 6 weeks. 
All 3 of the patients presented with spinal shock. (The remaining 2 patients 
with spinal shock had only 1 lumbar puncture each - 1 had a normal protein 
concentration and the other a protein concentration of 0,7 g/1). In the 
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other 3 patients who underwent a second lumbar puncture, the protein 
concentration remained normal in 2 and dropped from 0,5 g/1 to normal in the 
third. All 3 had hyperreflexia and hypertonia from onset. 
The CSF of the 6 patients who underwent repeat lumbar punture showed no 
significant change in the cell count in 2, a fall in 1 and a rise in 3. 
These changes did not parallel changes in CSF protein concentration. (e.g. 
-3 305 cells mm falling to 23 cells while CSF protein concentration rose from 
0,7 g/1 to 3 g/1). 
CSF glucose concentration was normal in all patients. CSF IgG/albumen 
ratios were measured in 5 patients. Four showed a normal ratio. In case No. 
4 (with associated brainstem disease) the CSF IgG gradient suggested local 
IgG synthesis as well as blood-CSF barrier breakdown. Lange colloidal gold 
curves were performed in 4 patients - 1 was normal and 3 showed a first zone 
reaction. All stains and viral cultures of CSF were negative. CSF cytology 
was negative and cryptococcal antigen absent in all patients. 
The ESR ranged from 5 to 140 mm (all but 3 were under 50). White cell 
counts were normal, except for patients with complicating infections. Tests 
for complement, anti-nuclear factor (ANF), rheumatoid factor, Epstein-Barr 
virus, mycoplasma, herpes zoster and cytomegalovirus antibodies were all 
negative. 
In 4 patients blood syphilitic serology was positive. In the first 
case, the Venereal Disease Research Laboratory (VDRL) test was positive to a 
titre of 1 and the fluorescent treponema antibody absorption (FTA-abs) test 
was positive. However the CSF was normal with negative VDRL and the patient 
later progressed to multiple sclerosis. Two patients had negative blood 
VDRL's but positive treponema pallidum haemagglutination test (TPHA). In one 
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the CSF was normal and he recovered fully without penicillin. In the 
other 
-3 
the CSF had 10 lymphocytes mm but the CSF VDRL was negative and the patient 
also improved without penicillin. The 4th patient had a blood VDRL positi
ve 
to a titre of 4 with positive blood TPHA. However, CSF was normal and C
SF 
VDRL negative. No penicillin was given and no improvement occurred. None of 
these patients were thought to have neurosyphilis at the time and illustrate 
some of the diagnostic difficulties that arise in a population with a high 
prevalence 
later. 
of latent syphilis. This aspect will be discussed in detail 
4.2.8. Management, Complications and Outcome 
Four patients received prednisone, 1 ACTH and 2 acyclovir. There was no 
convincing response. 
The early course was complicated by pneumonia · in . 1, urinary tract 
infection in 4, pressure sores in 3 and respiratory failure in 1. 
Two patients died, one from pulmonary emboli 8 weeks after onset and 1 
from undetermined causes. 
traced after discharge. 
Of the remaining 15 patients, 2 could not be 
The remaining 13 patients were followed for an 
average of 3 years 1 month (range 1 month - 7 years). Only 5 patients were 
followed for less than l! years 2 made a full recovery (follow-up 1 month 
and 6 months), 1 a fair recovery (follow-up 5 months) and 2 remained densely 
paraplegic (follow-up 10 months each). 
beyond 18 months. 
No patient continued to improve 
Recovery was assessed in terms of the criteria of Lipton and 
(101) 
Teasdall. Good recovery implied normal gait, minimal if any abnormal 
neurologic signs and micturition either normal or with minimal urgency. Fair 
recovery implied ambulation but with a spastic gait. Urgency of micturition 
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and constipation were frequently present and signs of spasticity and abnormal 
sensation were present. Poor recovery implied lack of ambulation with severe 
paraplegia and absence of sphincter control. Six patients (46%) made a good 
recovery, 5 a fair recovery (38,5%) and 2 a poor recovery (15,5%). 
Two patients developed multiple sclerosis by standard criteria(
126 ) and 
1 developed unilateral optic neuropathy 1 month after the onset of myelopathy 
(neuromyelitis optica). 
Outcome did not correlate with age, sex, sensory level, previous 
infection nor type of progression. However, both patients with poor outcomes 
presented with spinal shock, as did one patient who showed no recovery at 
time of death. Only 1 out of 11 patients with good or fair recovery 
presented with spinal shock. 
described earlier. 
The relationship : of CSF to severity has been 
4.3. DISCUSSION 
4.3.1 Clinical Aspects 
A. General 
The age range and lack of preponderance of either gender are similar to 
previous studies, as is the lack of relationship to seasons. The first 
symptom varies markedly but the commoness of pain 
this series it was the presenting complaint in 41%, 
must be emphasised. In 
similar to the 35%(l3l), 
45%(lOl) and 46%( 7 ) in previous studies. In any patient with an acute cord 
syndrome, space-occupying lesions must first be excluded but the presence of 
pain does not specifically point to a compressive pathology. 
B. Level 
All but 3 patients had a thoracic sensory level with the commonest site 
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being between T6 and T8 . 
d









blood-supply (see later) and this has been postulated as the reason for its 
vulnerability. 
C. Cerebra-spinal Fluid (CSF) 
The CSF was abnormal in 59% of patients, which correlates well with a 
previous report of 62%.(lS) In general, the cell count is usually less than 
300 mm-3 with a lymphocytic predominance(l3l) but isolated cases are found 
with extremely high counts (e.g.8800 cells)( 7) and with a marked neutrophilic 
predominance (e.g. 94%.Cl3l)) Protein concentrations can be raised up to 
Sg/1.(18) 
In the present study, an interesting finding was the marked rise in CSF 
protein concentrations in 3 patients presenting with spinal snack. Repeat 
analyses in 3 other patients with initial hyperreflexia and hypertonia did 
not show a rise. Although the numbers are too small to reach any firm 
conclusion, a possible correlation may exist and further prospective studies 
are needed. Only 2 previous studies have commented on follow-up CSF 
analysis. Rapper and Poskanzer(l3l) noted "2 patients with initially normal 
CSF protein had elevated protein when retested within 1 year" but give no 
further details. Paine and Byers(l20) found no consistent pattern. 
D. Outcome 
Although the period of follow-up was relatively short, no patients 
continued improving beyond 18 months. Of the 5 patients followed for less 
than that time, 2 recovered fully and 1 partially. 
The only correlate with poor outcome was spinal shock, a finding 
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previously noted.(lOl,l3l) The 1 patient with a hyperacute onset had a poor 
outcome in d P k 
, f' d ' (131) keeping with Rapper an os anzer s in ings. This study 
does not confirm their finding that backache correlated with poor outcome. 
4.3.2. Pathology 
It must be immediately recognised that the clinical spectrum of acute 
idiopathic myelopathy represents more than 1 pathological process. Early 
studies grouped together similar pathological entities whereas later studies 
described similar clinical pictures. Even today there is no clear 
formulation of the relative frequencies of different pathologies and their 
clinical correlations. As the prognosis improves with better supportive 
care, so less pathological material is available. In the present study only 
2 patients died and no autopsies could be obtained. In addition any 
pathological study is biased by the fact that only the more severe cases die 
and thus the milder cases are under-represented. 
In most cases the pathology falls into 1 of 2 groups with a spectrum 
showing some features of both. 
Firstly, a number of pathological studies have been reported describing 
a condition called variously progressive necrosis of the spinal cord,(ll
2) 
spinal necrosis and softening of obscure origin,(
82 ) acute myelomalacia and 
acute necrotic myelopathy.C 73 ) Clinically the picture has been that of a 
severe acute or subacute myelopathy. The basic pathology is an extensive 
necrosis of the grey and white matter of the cord often over a considerable 
longitudinal extent. The large anterior and posterior spinal arteries are 
patent, but in about 65% of autopsies(
73 ) medial and intimal hyperplasia has 
been noted in small intramedullary arteries and in some case also in larger 
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ones on the spinal cord surface. 
also been noted.(SS) 
Thickening of the walls of small veins has 
Secondly, some patients are found to have a predominantly demyelinating 
lesion with perivenous round cell inflammatory infiltrate.CZ) This 
is 
similar to the histology seen in acute disseminated encephalomyelitis (ADE) 
which can follow vaccination or infections including measles, mumps, rubella 
and . 11 (100,106)
 var1ce a. This in turn is similar to the histology seen in 
most cases of experimental allergic encephalomyelitis (EAE). This illness is 
induced by the injection of central nervous system basic encephalogenic 
protein (BE-protein) (one of the major components of CNS myelin) into 
laboratory animals. It is mediated chiefly by a delayed hypersensitivity T-
cell response and provides the best animal mode~ available for the study of 
acute myelopathy.(llO) 
The significance of these changes for an understanding · of possible 
aetiologies will now be discussed. 
4.3.3. Aetiological Factors 
A. Vascular Factors 
(1) Anatomical background 
The arterial blood-supply of the spinal cord comes from 3 longitudinal 
trunks and a number of segmental feeders.(lOS) 
(a) Anterior spinal artery. 
This arises from branches from the vertebral arteries which fuse to 
form a single vessel running downwards on the midline of the anterior surface 
of the cord. The general direction of blood flow is caudally. 
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(b) Posterior spinal arteries. 
These arise from the posterior inferior cerebellar arteries (2/3 of 
cases) or vertebral arteries (1/3 of cases). They run downwards in the form 
of anastomosing networks at the dorsal root entry zones. 
(c) Segmental arteries 
Each nerve root has a radicular artery arising from a segmental trunk 
artery e.g. in the dorso-lumbar region the radicular artery arises from the 
intercostal and lumbar branches of the aorta.C
35 ) These radicular arteries 
form 2 anastomatic nets, an outer net over the vertebral bodies and an inner 
net extradurally. 
Only a very few of the radicular arteries extend sufficiently far 
inwardly 
. : (144) 
to join the longitudinal spinal arteries. However, these few 
feeders are vital to maintaining the blood-supply _of . the cord as the 
descending arteries by themselves carry insufficient blood. Approximately 8 
feeders (range 2-17) augment the anterior spinal artery and 12 (range 6-25) 
h . . l . (35) augment t e posterior spina arteries. Most of these feeders join in the 
cervical and lumbar areas leaving the upper and mid-thoracic segments least 
supplied.Cl
44 ) In the thoraco-lumbar area there is one major feeder known as 
the Artery of Adamkiewicz (arteria radicularis magna). This is on the left 




The anterior spinal artery gives rise to central sulcal arteries which 
run posteriorly in the anterior median fissure and then divide to supply 
either the right 
alternate sides.C 6S) 
or left side of the cord. Successive arteries 
These are end arteries and do not anastomose, 
run to 
but the 
capillary beds of successive arteries overlap longitudinally running as much 
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as 3 cm up and down in the thoracic area.(
152 ) They supply the central 
portion of the anterior 2/3 of the cord (grey matter an
d inner white matter). 
The posterior spinal arteries give rise to penetratin
g branches which 
supply the dorsal columns and the posterior horns. 
A pial network formed 
from the anterior and posterior arteries is found on 
the cord surface and 
this supplies the superficial white matter by radial b
ranches.(l0
5 ) 
(2) Clinical Evidence 
(a) Dissociated sensory loss 
The preservation of position and vibration sense in ma
ny cases has been 
taken as evidence for the vascular nature of the lesion
 as this would fit the 
anatomical site corresponding to "anterior spin
al artery occlusions." 
' ( 101) 
Lipton and Teasdall found dissociated sensory 
loss in 10 out of 34 
patients and Paine and Byers(l
20) in 10 out of 25 children. However Ropper 
and Poskanzer(l
3l) found only 1 patient out of 52 with preservatio
n of 
position sense at onset and Altrocchi(
7 ) found dissociated loss in only 9 out 
of 67 patients. Thus the percentage of patients in 
the literature with 
preservation of posterior column sensation ranges betw
een 2% and 40%. 
In the present series position sense was spared in 8 o
ut of 17 patients 
(47%). This higher percentage probably reflects on
ly the diversity of 
disease manifestations rather than indicating a 
vascular aetiology. 
Obviously those series with stricter criteria requiri
ng severe transverse 
cord lesions will have a higher percentage with poste
rior column involvment. 
I believe the present study provides a fairer represen
taton of the disease 
spectrum. 
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(b) Brown-Sequard Syndromes 
An important finding of this study has been a high percentage of 
predominantly unilateral cord disease. Seven patients had variants of a 
Brown-Sequard syndrome, 4 with posterior column loss. A further patient 
commenced with a Brown-Sequard syndrome and progressed to a complete 
transverse lesion. 
Among the more recent large series, only Paine and 
( 120) 
Byers have 
mentioned 3 similar cases without adequate clinical details. 
in 1931 alludes to Brown-Sequard syndrome in acute myelopathy. 
McAlpine(l06) 
Cosnett( 27 ) 
describing 5 South African blacks with neuromyelitis optica noted that 2 had 
pictures suggestive of Brown-Sequard syndrome. 
(120) 
Paine and Byers feel these cases re~resent occlusion of a single 
central sulcal artery causing unilateral cord disease. On the contrary I feel 
that they are evidence against a vascular theory. Firstly, the posterior 
columns should have been preserved as they are supplied by the posterior 
spinal arteries and not the central sulcal arteries Secondly, there is 
considerable overlap as noted before between the longitudinal territories of 
supply of the central sulcal arteries. Thirdly, the patient whose illness 
progressed from root pain via a Brown-Sequard syndrome to a transverse 
myelopathy could not possibly have had a vascular aetiology - it is 
inconceivable that the central sulcal artery supplying the contralateral side 
of the cord at the same level should occlude at exactly the appropriate time 
to cause a smooth clinical progression. 
(c) Other 
The sometimes relatively slow onset and ascending nature of the disease 
have been used as arguments against a vascular cause. However the unusual 
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. . 1 . d "b d . h h d . f t " (
79 ) k 
clinica pictures escri e wit at eromatous cor in arc ion ma e 
these 
arguments less impressive (see below for further details). 
(3) Pathological Evidence 
Since last century certain pathological studies have led many authors to 
postulate that acute myelopathies are vascular in origin.Cl
2
0) In 1902 
Singer(l40) found that 17 out of 19 cases of so-called acute myelitis had 
apparently either syphilitic or atheromatous vascular disease. Sin
ce then 
the pendulum has swung away from this aetiology but pathological evidence in
 
its favour needs discussion. 
(a) Acute Necrotic Myelopathy 
As described above the large vessels in t~is condition are patent, but 
in about 2/3 of cases small vessels show hyperplasia of their walls. These 
features have been quoted in support of a vascular origin for ·the pathology,
 
but today most authorsC
73 ) feel they are probably due to the same insult that 
causes the myelopathy. Certainly the 1/3 of cases of acute necrotic 
myelopathy without vascular changes do not differ in any other pathological
 
or clinical way from those with them. 
(b) Atheromatous spinal cord infarction 
A different approach to this problem is to examine studies of spinal 
cord infarction due to atherosclerosis and to compare the clinical picture
 
with that of idiopathic myelopathy. In spite of the restricted nature of the
 
cord blood-supply, spinal cord infarction is rare. No cases were found in an
 
autopsy study of 3737 examinations performed between 1909 and 1958 at the 
National Hospital for Nervous Diseases, London.(
52 ) 
However more recent clinico-pathological studies have generally agreed 
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on the following aspects: 
(i) The clinical picture is often subacute or chronic rather than 
acute. ( 79 ) 
(ii) The anterior and posterior spinal arteries are remarkably preserved 
(iii) 
from atheroma. Jellinger(SS) found in 1037 unselecte
d autopsy 
cases atherosclerosis in major spinal cord arteries in only 12,7%. 
This was mild or moderate non-stenosing in 12,3% and showed 
obstruction or plaque formation in only 0,4%. Atheroma of the 
radicular feeding arteries or small intramedullary arteries was 
even rarer. In one French study(
63 ) of 19 spinal cord infarcts, 
the anterior and posterior spinal arteries were normal in all. 
The major cause of atheromatous cord infarction is disease of the 
segmental arteries where they leave the aorta either due to 
. (52 69 79) 
atheromatous plaques or aortic aneurysms. ' ' The origin of 
these arteries from the aorta is at a 90 degree angle and thus 
partial occlusion of the orifices may lower distal pressure more 
than if the angle was more obtuse.(SS) 
(iv) The site of cord infarction is variable and does not always follow 
clear-cut vascular territories. Conventional "anterior spinal 
artery syndrome" infarction does occur but it is not the rule and 
almost never seems to be due to atheromatous anterior spinal 
artery thrombosis. In some patients watershed infarction between 
anterior and posterior spinal artery territory has been found.C
52 ) 




Thus these studies provide little evidence by extrapolation from 
atheromatous disease for a vascular theory for most cases of acute idiopathic 
myelopathy. 
(c) Definite vascular lesions. 
Some cases of acute myelopathy are undoubtedly due to vascular causes 
but these entities are the minority. Lipton and Teasdall(lOl) found an 
unexpected intramedullary capillary telangiectasis with haemorrhage in one 
spinal cord at autopsy and Altrocchi( 7) reported 1 arteriovenous malformation 
found at laminectomy in his series of 67 patients. Mair and 
(104) Falkerts 
described a patient with extensive longitudinal thrombophlebitis of the 
anterolateral venous system of the spinal cord with patchy cord infarction 
and normal arteries. 
B. Infective factors 
There is considerable evidence that at least some cases of acute 
idiopathic myelopathy are related to infections. 
(1) Relationship to non-specific infectious illness. 
Twenty-five percent of illness in the present study were preceded by an 
upper respiratory or non-specific viral type infection. 
series this percentage is 16%,( 7) 30%,Cl3) 31%' (131) 
In the 6 reported 
35%(18,101) and 
60%( 120) (the last in a series consisting only of children). 
(2) Similarity to acute myelopathy after infections by a specific pathogen. 
Acute myelopathy has been reported after many viral illnesses including 
1 b 11 h . k (109) . fl (124) . f . meas es, rue a, c ic en-pox, mumps, in uenza, in ectious mono-
nucleosis,( 138) polio, coxsackie B,Cl3 ) herpes zoster( 74 ) and herpes 
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simplex( 95 ) infections. Mycoplasma related myelopathy also occurs.(lS
9) In 
most cases the clinical picture is indistinguishable from idiopathic 
myelopathy. 
(3) Relationship to vaccination. 
Myelopathy following vaccination against 1
. (131) 
po 10 , small-pox,(lS) 
rabies and tetanus(lZ4) have been reported. 
(4) Clinical features 
Occasional patients have been reported with both an inflammatory poly-
neuropathy (Guillain-Barre· syndrome) (GBS) and an acute myelopathy. (Sl, 
138) 
The most commonly accepted hypothesis of GBS pathogenesis is that of an auto-
. f . f . (1,100) I . h immune process o ten post-in ect1ous. : ts occurrence wit acute 
myelopathy suggests the two may have similar mechanisms. 
The Brown-Sequard syndromes reported in the present study, especially 
the patient who progressed from radiculopathy to a complete transverse 
myelopathy, (case no 1) seem compatible with an inflammatory process. One 
might hypothesise, with herpes zoster as a model, an initiating factor 
infecting first a nerve root and then the spinal cord transversely. However, 
as discussed below, herpes zoster has only once been isolated from spinal 
cord tissue and such direct infection probably only occurs in a minority of 
cases. 
(7) Nature of the pathology 
As discussed above, the demyelinating form of acute myelopathy with 
perivenous inflammation resembles the pathology of ADE. This illness can 
follow measles, mumps, rubella, varicella and infectious mononucleosis,(lOO) 
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a list similar to the viral cases of acute myelopathy alone. Of special 
interest is case 4 in the present series where a cord and brainstem lesion 
evolved simultaneously. The histology of ADE is close to that of EAE and 
this similarity to an undoubtedly immune mediated illness provides further 
support for the possible role of infective factors in acute myelopathy. 
Even the alternative pathology of acute necrosis with little 
inflammation is similar to the hyperacute necrotising form of EAE.(l) This 
form is induced by injecting brain tissue combined with adjuvant and 
pertussis vaccine.(lOO) A further clinical condition with again similar 
histology is acute haemorrhagic leucoencephalitis which follows a non-
specific viral illness in 50% of cases.(llO) 
(6) Lymphocyte transformation studies. 
Apart from exceptional casesC 74 ,ss, 95 ) viruses are not isolated from the 
CSF or spinal cord of patients with acute myelopathy(
124 ) and the most 
plausible explanation is that a hypersensitivity reaction induced by the 
virus results in demyelination or necrosis. This may occur either as a 
parainfectious or postinfectious event. 
In one study(l) 7 out of 10 patients with acute myelopathy showed 
lymphocyte transformation in vitro in response to BE-protein and 3 out of 8 
to P2 basic protein (found in peripheral nerve but similar to CNS BE-
protein). No response occurred to PIL protein (found in peripheral nerve and 
purely neuritogenic) and none to acetylcholine receptor. No response 
occurred on retesting 6 patients some months after the acute event. Seven 
out of 9 patients with Guillain-Barre syndrome showed lymphocytic 
transformation to PIL protein only and controls with other neurological 
diseases showed no response to the antigens used. This suggests that the 
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response seen is relatively specific for cell-mediated cord damage but it is 
still unsure whether it represents the primary event or a secondary 
epiphenomenon. 
C. Relationship to Multiple Sclerosis (MS) 
Two of the 16 patients in the present series developed MS and an 
additional 1 developed unilateral optic neuropathy (19%). In previous 
studies, 2%,(lS) 3%,(lOl) 6%( 7) and 13%(l3l) progressed to MS or 
neuromyelitis optica. The slightly higher percentage in our study is 
interesting in view of the low incidence of MS in South Africa.CS) In 
general, acute myelopathy rarely progresses to a more generalised 
demyelinating disease. 
D. Other Factors 
Minor trauma sometimes precedes the onset of a my~lo~athy(?) as occurred 
in 1 of our patients. Toxins and drugs have been implicated including 
arsenicals, orthocresylphosphate, iodoxyquinoline, intrathecal 
penicillin( 124) and heroin.(SS) Unrecognised toxic or dietary factors have 
been postulated in the pathogenesis of chronic idiopathic myelopathy in South 
Af . (26,156) rica. (Collagen vascular disease and systemic neoplasia are 
discussed later). 
E. Conclusions regarding Aetiology 
Much uncertainty still remains. However present evidence suggests that 
the majority of acute idiopathic myelopathies represent a spectrum of immune 
reactions of the spinal cord to unknown external agents, many of which may 
well be infectious. A minority of cases are vascular in origin and a few 
represent the first episode of multiple sclerosis. 
34. 
4.3.4 Therapy 
No adequate clinical trials have been performed on the use of steroids 
in acute idiopathic myelopathy. Anecdotal reports of their uncontrolled use 
in a few patients( 36 ) give little assistance. The only controlled trial(ll
9 ) 
compared oral and intramuscular steroids, intrathecal steroids and 
"antibiotics". The diagnostic criteria were inadequate, the trial does not 
appear to have been randomised or blinded and the clinical details were 
scanty. The authors found a statistically significant improvement only with 
intrathecal steroids but the design errors make the results worthless. 
At present there are no guidelines that can be offered and clinicians 
should judge each case individually. If steroids are used, they should not 
be continued for long periods if there is no clinical response. 
35. 
5. SYPHILITIC MYELOPATHY 
5.1. Case reports 
Seven patients with acute or subacute myelopathy due to neurosyphilis 
have been identified. Three representative case reports with comments 
follow. 
Case No. 5. 
A 24 year old black male was treated at a venereal disease clinic for a 
urethral discharge in February 1983. Venereal Disease Research Laboratory 
test (VDRL) was negative. In July 1983 he developed coldness and disturbed 
sensation in his legs followed by leg weakness which progressed over 8 days. 
Urge incontinence also developed. 
On examination the normal findings were confined to the trunk and legs. 
He had a spastic hyperreflexic weakness of both legs more marked on the 
right. 
ankle. 
Power ranged between 3 and 5/ 5. Clonus was ., elicited · at the right 
Abdominal and cremasteric reflexes were absent. Plantar responses 
were flexor. There was decreased position and vibration sense in the right 
foot. Pain and temperature sensation were normal. He walked with a wide-
based gait. Romberg's sign was positive. 
Spinal x-rays and a myelogram were normal. 
protein concentration of 1,2 g/£, 4 + globulin, 
CSF examinations showed a 
-3 
204 lymphocytes mm and a 
Lange colloidal gold curve of 122243221. CSF VDRL was positive to a titre of 
1 and CSF Fluorescent Treponema Antibody-Absorption (FTA) test was positive. 
In the blood VDRL was positive to a titre of 64 and the Treponema pallidum 
Haemagglutination test (TPHA) was positive. 
He was treated with benzyl penicillin G twenty million units daily 
intravenously for 12 days followed by 10 days of 900,000 units daily of 
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procaine penicillin intramuscularly. By 
September 1983 proprioception was 
normal and power in the legs almost full. 
performed. 
No follow-up LP was apparently 
Comment 
This patient illustrates the development over 1 w
eek of a myelopathy due 
to meningovascular syphilis affecting the postero
lateral portion of the cord, 
occurring at most 5 months after a primary infect
ion. 
response to treatment. 
There was a marked 
Case No. 6. 
A 20 year old coloured male developed cervical an
d thoracic backache in 
September 1979. Ten days later he developed :w
eakness of the legs which 
rapidly progressed to a complete paraplegia w
ith urinary retention and 
constipation. He recalled a urethral discharge 3 
year·s previously. 
On examination, abnormal signs were confined to 
the legs. He had a 
total flaccid areflexic paraplegia with absent abd
ominal reflexes. There was 
a sensory level at the 7th thoracic dermatome bel
ow which all sensation was 
absent. Anal tone was flaccid. 
Spinal x-rays and a myelogram were normal. CSF ex
amination showed 1 g/1 
protein, 3 + globulin, 
-3 
127 neutrophils and 920 lymphocytes mm . 
VDRL was positive to a titre of 32 and the CSF FTA wa
s positive. 




He was treated with 20 million units benzyl peni
cillin G intravenously 
daily for 2 days followed by 12 days procaine pe
nicillin 1,2 million units 
daily intramuscularly. No recovery occurred and when 
last seen in September 




This patient illustrates the rapid development of a complete transverse 
cord lesion following 10 days of backache. 
recovery occurred. 
Case No. 7. 
In spite of treatment no 
A 31 year old previously well coloured female was found to have a VDRL 
positive to a titre of 8 at an antenatal clinic in November 1979 during her 
3rd pregnancy. Apparently no treatment was given. In March 1980 she 
developed headache and drowsiness. On examination a complete left third 
cranial nerve palsy was found with mild right hyperreflexia. There was neck 
stiffness, bilateral fundal haemorrhages and a subhyaloid haemorrhage on the 
left with papilloedema. Her blood pressure was 
0
170/llO mm Hg. 
A CT scan of the head was normal. No LP was performed but . a presumptive 
diagnosis of pre-eclamptic toxaemia with a subarachnoid haemorrhage was made. 
However 4- vessel angiography was normal. The patient developed pulmonary 
oedema and transient acute renal failure and emergency caesarian section was 
performed. The final diagnosis was of a mid-brain infarct. 
She was then well until November 1980 when she developed 5 days lower 
back pain and headache. On examination she had a dilated left pupil and 
right hyperreflexia. There was marked neck stiffness. An LP showed a 
protein concentration of 0,8 g/1, 1 + globulin, 190 neutrophils, 9 lympho-
-3 
cytes and 20 red blood cells mm . Glucose concentration was normal and no 
organisms were cultured. 
was discharged. 
A diagnosis of viral meningitis was made and she 
One week later she developed mild leg weakness and then 2 days later a 
sudden complete paraplegia with absent sensation and urinary retention. A 
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further 5 days later she developed a pain in the neck and left arm followed 
by paralysis of the left arm. 
On examination the left pupil was slightly larger than the right and did 
not react to light but constricted to accomodation. Both arms were weak, the 
left completely paralysed and areflexic, the right with 3 - 4/5 power and 
preserved reflexes. There was a complete flaccid areflexic paraplegia with 
absent abdominal reflexes. There was a sensory level at T2 dermato
ne on the 
right and T4 on t
he left below which all sensation was absent. 
A repeat LP revealed turbid fluid with protein concentration greater 
than 4 g/1, 2+ globulin, 33 neutrophils, 
-3 
99 lymphocytes mm and normal 
glucose concentration. The CSF IgG/albumin ratio was 20%. All cultures were 
negative. CSF VDRL and FTA were negative. Blood VDRL was positive to a 
titre of 8 and TPHA was positive. 
swelling from c2 to T9 . 
A myelogram revealed a diffuse cord 
Treatment with one million units procaine penicillin intramuscularly 
daily and dexamethasone was commenced. Intercostal and diaphragmatic 
weakness developed and she required temporary supportive ventilation. 
Improvement commenced 8 weeks after treatment started. By 5 weeks (December 
1980) she had normal sensation and bladder function, power in the right arm 
was full, power in the left arm and left leg was grade 4/5 with spasticity 
and the right leg had grade 2/5 power. 
However in January 1981 her left arm and leg again became weak. CSF then 
I 
-3 
showed a protein concentration of 0,4 g 1 with 3 lymphocytes mm. CSF, 
VDRL and FTA were negative. Blood VDRL titre was 4 and TPHA remained 
positive. By March 1981 both legs and the left arm were again completely 
paralysed with a new sensory level at T8
. A repeat myelogram showed 
39. 
arachnoiditis from T12 
upwards with a complete block to the flow of myodil at 
T
6




myelogram showed a protein concentration of 0,8 g 1 and 8 lymphocy
tes mm. 
The patient died suddenly in April 1981. No autopsy was performed. 
Comment 
This patient demonstrates the acute development of a severe myelo
pathy 
with a swollen cord similar to that seen on myelography in some pat
ients with 
pathological findings of acute necrotic myelopathy. She made a
 remarkable 
recovery followed by a secondary deterioration related to the devel
opment of 
arachnoiditis, probably secondary to the meningitis rather than
 to the 
initial myelogram. In spite of the negative CSF serology the pictu
re was 




consequences of failing to react to positive blood 
5.2. Results 
5.2.1. General 
Five patients were male, 2 female. Six coloured and 1 black. The m
ean 
age was 33 years (range 22 58). Only 2 patients had previous histories of 
venereal disease - 1 five months and 1 three years before. 
5.2.2. Clinical features 
Four patients commenced with backache, 2 with sensory symptoms an
d 1 
with weakness. However, 5 of the 7 developed pain at some stage of the 
illness and 6 of the 7 sensory signs (only 1 sparing posterio
r column 





All 7 patients developed leg weakness - 3 with hypertonia and power of 3 
to 5/5 and 4 with flaccid areflexic paraplegia ("cord shock"). One patient 
had arm weakness. Six of the 7 had urinary and 4 faecal symptoms. 
As regards the course of the illness, 2 groups were identified. Three 
patients (e.g. Case No. 5) followed a progressive course over 6 days, 8 days 
and 7 weeks respectively with a moderate spastic paraparesis on admission. 
The 2nd group of 4 patients (e.g. Case No. 6) all developed "cord shock". 
All had a prodromal phase of 6 days to 6 weeks mild weakness (3 of the 4 
associated with backache). Then in all 4 patients a second phase of rapidly 
developing paraplegia occurred over 1 to 5 days. 
In all patients but one (Case No 7) the signs were restricted to the 
spinal cord. 
5.2.3. Laboratory Investigations 
The blood VDRL was positive in all 7 patients with a titre of 8 - 1024. 
The TPHA was also positive. 
A CSF pleocytosis was found in all patients, ranging from 7-920 cells. 
Three patients had more than 200 cells. In 5 patients lymphocytes 
predominated, in 2 neutrophils (54% and 91% respectively). Protein 
concentration was raised in 6 of the 7 ranging from 0,2 and 4.0 g/1. Only 12 
patient exceeded 1,2 g/1. CSF glucose was normal in all patients. CSF VDRL 
was positive in 5 of the 7 (titres 1-32). Both the patients with negative 
CSF VDRL had a CSF pleocytosis, had positive blood VDRL (titres 8 and 128) 
and positive blood TPHA. One of the 2 had a positive CSF FTA test. 
Myelograms were normal in 5 patients. In 1 patient it was not performed 
as the diagnosis was obvious and in 1 (Case No 7) it showed cord swelling. 
41. 
The ESR ranged between 15 and 114. The white cell count was normal in all 
patients. 
5.2.4. Treatment and outcome 
Treatment consisted of procaine penicillin 900 000 to 1,2 million units 
intramuscularly daily for 10 - 14 days in all patients. This was preceded by 
a few days intravenous benzyl penicillin Gin a dose of 20 million units 
daily in 3 patients. 
Only 
(101) 
1 patient (Case No 5) made a good recovery. Another patient 
made a fair recovery and a 3rd (Case No 7) improved before secondary 
deterioration related to arachnoiditis. The other 4 patients did not improve 
but flaccid paraplegias became spastic with time. Only 2 patients had 
follow-up lumbar punctures - in both the CSF had returned to normal. 
did not appear to be any factors which could predict improvement. 
There 
5.3. Additional Cases 
Two additional cases with spinal cord neurosyphilis not fulfilling the 
criteria of this study are now described separately. One of these progressed 
over 4 years and the other had an extradural mass on myelography. 
Case No 8. 
A 34 year old previously well coloured male was admitted in May 1981 
with a 4 year history of slowly progressive leg weakness and a 6 months 
history of urgency incontinence. 
to his legs. 
On examination abnormalities were limited 
He had a spastic hyperreflexic paraparesis with grade 4 - 5 weakness, 
the left leg being slightly weaker than the right. Plantar reflexes were 
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extensor. There was patchy loss of pain and touch sensation below the knees 
and impaired position and vibration sense in the feet. 
A myelogram was normal. CSF showed a protein concentration of 0,4 g/1, 
a trace of globulin, 
CSF VDRL was positive. 
-3 4 lymphocytes mm and a normal glucose concentration. 
The blood VDRL was positive to a titre of 8 and TPHA 
was positive. Serum folate and vitamin B12 concentrations 
were normal. 
He was treated with 2_000 000 units procaine penicillin intramuscularly 
daily for 3 weeks. There was minimal improvement. Repeat CSF examination in 
December 1982 showed a protein concentration of 0,2 g/1, a trace of globulin 
and 10 -3 lymphocytes mm In July 1983 CSF examination showed a protein 
concentration of 0,2 g/1 and no cells. The blood VDRL titre had fallen to 4. 
Comment 
This patient demonstrates a slowly progressive mainly motor myelopathy 
over 4 years due to syphilis. 
Case No. 9 
A 64 year old coloured female with maturity-onset diabetes developed 
gradual onset of progressive weakness in both legs in June 1984. 
associated with difficulty in micturition. 
This was 
Abnormal findings were confined to the legs. 
reflexic paraparesis with power of grade 3-4/5. 
She had a spastic hyper-
Abdominal reflexes were 
absent. Plantar responses were flexor. Sensation was intact. 
Spinal x-rays were normal except for mild degenerative changes. A 
myelogram showed an incomplete left extradural obstruction of 4 cm at the 
level of T4 . There was also mild spondoly
tic cervical cord narrowing. CSF 
showed protein concentration of 5 g/1, 
-3 3 + globulin, 342 lymphocytes mm , 7 
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neutrophils mm-3 and normal glucose concentration. CSF VDRL was positive. 
Blood VDRL was positive to titre of 256 and TPHA was positive. 
She was treated with procaine penicillin 1 000 000 units daily intra-
muscularly for 21 days. There was no neurological improvement. A repeat 
myelogram 7 weeks later showed the extradural lesion to be definitely 
smaller. Further CSF and myelographic follow-up is planned. 
Comment 
This patient probably represents a patient with syphilitic hypertrophic 
pachymeningitis. She undoubtedly has neurosyphilis and the myelographic 
picture is suggestive of .the extradural inflammatory lesions seen usually in 
the cervical region. 
5.4. Discussion 
5.4.1. Clinical picture of spinal cord syphilis 
Most of the clinical literature on neurosyphilis predates the use of 
penicil~in. In the last 35 years descriptions of spinal cord syphilis have 
been restricted to case reports(
47 , 65 ) usually of 1 patient only and large 
series of neurosyphilis as a whole(
77 , 98 ) in which clinical descriptions of 
individual types are very limited. In spite of the frequent assertion that 
the pattern of neurosyphilis is changing,C
77 ,l02) careful large clinically 
orientated studies are few.( 122 ) 
Neurosyphilis is thought to arise by asymptomatic infection of the 
meninges early in the course of the disease. (l0
8 ) In 1 study(ll6 ) 11% of 
patients were shown to have abnormal CSF 3 months after primary infection and 
33% by 18 months. In another study(lll) 9% of patients with primary syphilis 
had CSF abnormalities as did 35% with secondary disease. 
44. 
A. Pre-penicillin studies 
The 
Merritt 
most definitive study of neurosyphilis is the 1946 monograph 
et al(lOS) and any analysis of more recent data must start with 
of 
a 
detailed look at their findings. They classify spinal cord syphilis into 5 
groups: 
1. Syphilitic .meningomyelitis (including such variants as amyotrophic 
meningomyelitis and syphilitic spastic paraplegia known Erb's paralysis). 
2. Spinal vascular syphilis (equivalent to acute transverse syphilitic 
myelitis). 
3. Syphilitic spinal pachymeningitis (including (a) spinal cord gummata and 
(b) syphilitic hypertrophic pachymeningitis) 
4. Syphilitic poliomyelitis. 
5. Cord compression by aortic aneurysm or vertebral gumma. 
Twenty-nine cases were described. The commonest group was meningo-
myelitis (15 patients). The basic lesion is chronic inflammation of spinal 
meninges with inflammatory invasion of the cord parenchyma. Although the 
authors classify spinal vascular syphilis as a separate group, they admit 
that in many cases both meningomyelitis and vascular occlusion due to 
endarteritis play a role. The latent period in this group ranges from a few 
months to 25 years. 
rather than acute. 
In most cases the illness was insidious and progressive 
Position sense loss occurred in 46% but a spinothalamic 
sensory level occurred in only 33%. Lower motor neurone signs were seen in 
the arms in 27% and in the legs in 13%. Associated mental symptoms occurred 
in 26%; cranial nerve palsies in 13% and abnormal pupils in 46%. Thus 
isolated spinal cord disease was not common. 
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The variant of Erb's syphilitic paraplegia refe
rs to cases(l
60) with a 
very slow onset and a slowly progressive largely mot
or paraparesis over a 
course of years. Erb's original cases did not include 
any pathology and the 
condition probably is not a separate clinical en
tity.(lOS) Similarly, 
syphilitic amyotrophy does not usually occur alone bu
t in the form of lower 
motor neurone signs in a patient with other evidence o
f cord disease.(lOS, 
160) 
Merritt et al's(lOS) second group of spinal vascular s
yphilis consisted 
of 10 patients with sudden onset of complete transverse m
yelopathy with total 
distal loss of function. They comment that it is clea
rly a separable entity, 
but can complicate cases in the first group. The pathol
ogy is cord necrosis 
due to Heubner's endarteritis of small vessels~ lymp
hocytic and plasma cell 
infiltration with subintimal fibroblast proliferation. 
Four cases of syphilitic spinal pachymeningitis are de
scribed - 3 with a 
localised gumma presenting as a spinal cord tumour and
 1 with hypertrophic 
pachymeningitis. This patient presented with sensor
y symptoms and lower 
motor neurone signs in the hands and progressed slow
ly over 18 months to a 
spastic paraparesis. Lumbar puncture revealed a pictur
e of spinal block. At 
autopsy thickened cervical and thoracic meninges (espe
cially dura) were found 
with infiltration by chronic inflammatory cells and fib
roblasts). 
Only 1 patient with syphilitic aortic aneurysm compres
sing the cord was 
seen and none with vertebral gummata. 
CSF protein concentration in the group as a whole rang
ed from 0,4 - 2,4 
g/1 (with exception of spinal pachymeningitis when it
 rose up to 9,2 g/1). 
Cells 
-3 
ranged from 10 - 360 mm . Glucose concentration was us
ually normal 
but occasionally low. Merritt et al(lOS) were p
repared to accept negative 
46. 
CSF Wasserman reactions (WR) (13% - 3 cases) in the presen
ce of positive 
blood serology. It is not clear whether the 13% all had a CS
F pleocytosis. 
As regards frequency, spinal cord syphilis was rare in pro
portion to 






How has the picture of the disease changed? An idea of frequ
ency can be 
gauged from several series published after 1955. Kofman(
9S) reported 177 
patients with neurosyphilis in 1956. Only 17 had meningova
scular syphilis, 
the number with the spinal form not being specified. W
oods (1956)(
161 ) 
described 24 cases of neurosyphilis in Bantu males of whom 
7 had meningo-
myelitis and 1 a spinal gumma. However, he notes that his 
sampling method 
would have excluded many patients with general paresis .and 
therefore his 
ratios are inaccurate. Very few clinical details are given. 
In 1972 Hooshman et al(
77 ) studied 241 patients with neurosyphilis 
collected over a remarkably short time of 5 years from the te
aching hospitals 
of 1 United States university. No attempt is made to g
roup the cases 
conventionally, but it would seem that 9 (4%) may have had co
rd syndromes. 
Luxon et al (1979)(l0
2) described 17 neurosyphilis patients from a 
London hospital. Of these 2 had definite spinal cord syphi
lis and 1 had 
sciatica with myelographic arachnoiditis but no CSF pleoc
ytosis and VDRL 
positive only in the blood. This is a frequency between 12 a
nd 18%. 
Gelfand et al. (1980)(
54 ) described 39 cases in Zimbabwean Africans. He 
notes that tabes dorsalis is rare and reported 5 cases with
 satisfactorily 
documented spinal cord syphilis - a frequency of 12,5%. 
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A thorough epidemiological study from Denmark(
122 ) found 55 cases of 
neurosyphilis between 1971 and 1979. Of these, 3 apparently had meningo-
myelitis (very few clinical details given) and 1 hypertrophic pachy-
· · · ( 3) f f 7 3% men1ng1t1s - a requency o , o. Over 15 years in Leicester, Alani and 
Millar( 6) reported 1 patient with syphilitic myelopathy in a series of 20 
(5%). 
From a different view point, Bahemuka(l
3 ) found only 1 patient with a 
syphilitic cause in 23 patients with acute transverse myelopathy in Kenya. 
Wallace and Cosnett(
156 ) list meningovascular syphilis as a cause of only 1% 
of all black patients presenting to their Durban hospital with paraplegia. 
Thus attempts to reach a conclusion on the relative frequency of spinal 
syphilis today is hampered by inadequate information and sampling problems. 
One might well expect the frequency to differ in differing countries. The 
figures from the countries quoted range between 4 and 18%. In general they 
are slightly higher than the 3% of Merritt et al. (l0
8) but when a study with 
good 
(122) 
sampling methods is used in a developed country, it is still only 
5%. Most studies from hospital departments especially in developing 
countries will underestimate the incidence of general paresis as these 
patients are often seen primarily in psychiatric hospitals. 
(2) Clinical pattern 
There are remarkably few descriptions in the modern literature of the 
clinical features of spinal syphilis. Fifteen cases of what Merritt et 
al.(l08) would have called meningomyelitis or spinal vascular syphilis can be 
gleaned from the literature with at least some clinical details 
. (47,54,65,86,87,102) I . "bl h 2 given. tis not poss1 e to separate t ese groups. 
48. 
The length of history varies from "sudden onset of paraplegia"(S
7) to 2 




All but 3 had symptoms under 2 months. Sensory signs are only mentio
ned in 7 
in 2(l02) sensation was normal, in 2 all modalities were affected,C
65 ,S7) 
in 2 proprioception 
(47 87) 
was spared ' and in 1 only vibration sense was 
affected. (S7) 
only. (S"?) 
Power loss varied from complete paraplegia to mild spasticity 
VDRL was positive in all but 2 cases in whom the CSF FTA was 
positive.CS
7) As neither of these 2 had a CSF pleocytosis, the diagnosis is 
doubtful. Of interest are 2 well documented patients with low
 CSF glucose 
. (47 65) 
concentration compared to blood. ' 
Two well documented cases of syphilitic pachymeningitis have b
een 
described in the last 30 years. In 1972 Gribble~
59 ) described a patient from 
Groote Schuur Hospital with a 6 week history of backache and leg 
weakness 
resulting in a spastic paraparesis with sensory loss for all modali
ties. A 
myelogram showed a concentric compressive extradural lesion at c7 and c8 . 
CSF showed a pleocytosis but normal protein concentration and p
ressure, 
contrary to the experience of Merritt et al.(lOS) The blood VDRL was 
positive but the CSF WR- negative. After 3 weeks of treatment a r
epeat 
myelogram was normal and the clinical signs had improved markedly. In 
1980 
Agdal et a1f
3) described a patient with a 6 month history of spastic 
paraparesis who at surgery was found to have a cervical extradural 
granulo-




lymphocytes mm and a positive VDRL. Woods(
161 ) alludes to. 1 patient 
with 3 gummata found at surgery. 
As regards myelographic arachnoiditis, Wadia and Dactur(lSS) found t
hat 
syphilis accounted for only 4 of their 70 patients in India and 2 o
f these 
49. 
had negative serology. One further case of myelogr
aphic arachnoiditis is 
described by Luxor(lOZ) with minimal signs, positive 
blood VDRL but negative 
CSF VDRL and no pleocytosis. 
C. Present study 
The 9 patients reported here make up one of the larges
t series with full 
clinical details since the study of Merritt et al.(lOS
) No attempt has been 
made to estimate the relative frequency of spinal 
cord syphilis in the 
present study as the overall number of neurosyphilis 
patients in Cape Town 
seen over the same period is unknown. 
In keeping with other studies in the modern litera
ture it is not 
possible to separate out cases of meningomyelitis fro
m vascular syphilis. 
Eight of the 9 patients fell within these groups (89%
), very similar to the 
86% of Merritt et al. These 8 fell into 3 groups -
3 patients followed a 
slowly progressive course over less than 2 months
, 4 patients had a 
prodromal phase, during which time treatment might 
have aborted disaster, 
followed by rapid development of severe paraplegia. 
This group probably 
represents an inflammatory process culminating with an
 acute vascular episode 
and is the nearest one sees today of Merritt et 
al's "spinal vascular 
syphilis". The eighth patient had a slowly progress
ive course over 4 years 
with mainly motor involvement. This is a rare presen
tation, but should be 
remembered when assessing chronic parapareses. The p
athology is probably no 
different from the rest of the group. 
grouping of Erb's variant.Cl
60) 
Historically it falls under the 
The ninth patient probably had syphilitic pachym
eningitis in the 
thoracic region. Merritt et al's case had cervica
l and thoracic dural 
so. 
inflammation, whereas the other 2 patients described above(
3 , 59 ) had cervical 
inflammation only. 
myelographically. 
One of these 2 and the present patient were diagnosed 
CSF protein concentration was markedly raised. If such a 
lesion is seen and the CSF serology is positive, a course of treatment should 
be given and the myelogram repeated before surgical intervention is 
considered. 
One of our patients developed secondary arachnoiditis. The role of 
syphilis in the pathogenesis of myelographic arachnoiditis is uncertain - it 
is definitely very uncommon and other diagnoses should be considered first. 
Myelogram in syphilitic meningomyelitis is usually normal. 
Seven of the 9 patients had sensory loss and of these only 1 spared 
position sense. This should be compared to 50% of the idiopathic group who 
showed sensory dissociation. Syphilis seems to have a predeliction for 
posterior column damage - tabes dorsalis is another example of this. 
All except the patient who progressed over 4 years had raised CSF cell 
counts. While the majority had lymphocytic predominance, 2 of the 8 (25%) 
had initially more neutrophils. This does not exclude the diagnosis. 
Similarly 2 of the 9 patients had normal CSF protein concentration (22%). 
All the patients in the present series had normal CSF glucose concentrations, 
but 3 of the patients in the recent literature(
47 , 59 , 65 ) (1 with pachy-
meningitis) had CSF glucose about 1/3rd of blood glucose concentration. No 
patient had extremely low levels. 
5.4.2. Laboratory criteria for diagnosis 
No authoritative criteria for the diagnosis of neurosyphilis have ever 
been laid down. Merritt et al(lOS) included patients with negative CSF 
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serology and no pleocytosis. With the development of specific anti-
treponemal antibody tests such as FI'A,CS
3) the picture has become confused. 
As regards blood tests, the nonspecific reaginic antibody tests such as 
VDRL are said to be less sensitive for tertiary syphilis than specific tests. 
Holmes,C 75) quoting data from the USA Centre for Disease Control, maintains 
that 13% of patients with tertiary syphilis are VDRL negative but FI'A 
positive. However my personal experience is that in meningovascular 
syphilis as opposed to general paresis or tabes dorsalis, a negative blood 
VDRL but positive TPHA or FI'A is exceptionally rare. In the present series 
all 9 patients had a positive blood VDRL. As discussed earlier, 2 patients 
with idiopathic myelopathy had negative blood VDRL but positive TPHA. In 
both the CSF VDRL was negative and both improve~ without penicillin. It is 
accepted today that in spite of higher sensitivity for primary and some forms 
.. . 
of tertiary syphilis, the FI'A should not be used as a screening test because 
of it expense and its technical difficulty leading to reduced reliability in 
unskilled hands.C 3l,S3 ) 
In the CSF three problems arise. Firstly, what is the significance of a 
positive CSF VDRL with a normal cell count? A positive CSF VDRL is 
considered by some(
4S) virtually diagnostic of neurosyphilis if there has 
been no obvious blood contamination of the specimen. Other authors insist on 
1 . (161) . b a p eocytosis or in a sence of an initial pleocytosis, either obvious 
clinical improvement with therapy or the development of a pleocytosis with 
treatment.C
77 ) It would appear that while the presence of increased cells in 
the CSF is not essential it is at least desirable. 
Secondly, what is the role of CSF FI'A? Some authorsC
42 , 77 ,S7 ) have 
advocated its use in place of the CSF VDRL and there is 1 
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( 150) report of 
Treponema pallidum isolated from CSF in the presence of a positive CSF FTA 
but negative CSF VDRL and normal cell count. Considerable doubts however 
have developed. Apart from the difficulty and expense of the test, there is 
some evidence that CSF specific antibodies depend on the presence of 
· 1 · 1 b 1· d · d f h (
4S) Two studi·es(S4 ,l5l) circu atory immunog o u in erive ram t e serum. 
have shown that the CSF FTA titre is significantly lower than the same titre 
in the blood, supporting the possibility of antibody diffusion. Whether this 
would imply 
study( 33) has 
some blood-brain barrier breakdown is uncertain. However 1 
shown that as little as 0,005 µl serum or 42 red blood cells 
mm-3 contamination of CSF with the patient's own blood at LP is sufficient to 
convert a negative CSF FTA to positive. Far more blood is needed to convert 
a CSF VDRL. Thus the consensus today seems to be , that the FTA test should 
not be used in the CSF as a diagnostic criterion for neurosyphilis.C
4S) 
Thirdly, what is the significance of a positive -serum VDRL but a 
negative CSF VDRL? Almost all series accept a certain percentage of patients 
in this group as having neurosyphilis. Merritt et al(lOS) for instance, 
noted 28% of their tabetics, 12.5% of their patients with cerebral meningo-
vascular syphilis and 13% with spinal meningovascular syphilis had negative 
CSF WR's. It can of course be argued that some of these patients did not in 
fact have neurosyphilis, but the fact remains that authors with experience of 
the clinical and pathological features were prepared to accept the diagnosis. 
Most subsequent authors followed this lead(
4S, 77 ) while a very few have 
insisted on the stricter criterion of a positive CSF WR.(
161 ) There can be 
no definite answer to this problem as the absolute diagnostic standard is 
pathology which today is rarely available. Merrit et al unfortunately did 
not include among their many case histories any patients with negative CSF WR 
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and autopsy confirmation of the diagnosis. However the acceptance of 
patients with negative CSF VDRL as having neurosyphilis if the clinical 
condition is compatible, blood serology is positive and there is a CSF 
pleocytosis falls within the realm of reasonable clinical practice. 
With this background, I suggest the following laboratory criteria for 
the diagnosis of meningovascular syphilis in an appropriate clinical setting: 
1. Definite neurosyphilis. 
(a) Blood non-specific (VDRL) and specific (TPHA or FfA) test positive. 
(b) CSF VDRL positive and a CSF pleocytosis. 
2. Probable neurosyphilis. 
(a) Blood non-specific (VDRL) and specific (TPHA or FI'A) test positive. 
(b) Either CSF VDRL negative but CSF pleocytosis present 
or 
CSF VDRL positive but normal CSF cell count. 
3. Possible neurosyphilis. 
(a) Blood non-specific (VDRL) test negative but specific (TPHA or FI'A) 
test positive. 
(b) CSF pleocytosis. 
If the CSF is entirely normal with respect to cells and serology, 
extreme caution should be exercised in diagnosing meningovascular 
syphilis. (These criteria do not apply to parenchymatous neurosyphilis, 
especially tabes dorsalis, where fewer positive tests are required in 
the correct clinical setting). 
In the present series 7 of the 9 patients fulfilled the criteria for 
definite neurosyphilis and 2 the criteria for probable neurosyphilis. Of the 
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4 patients classified as idiopathic myelopathy with positive blood serology 
(see earlier), only 1 fulfilled even the criteria for possible neurosyphilis 
and none for probable or definite neurosyphilis. 
5.4.3. Therapy 
The recommendations of the Centre for Disease Control at Atlanta, 
G . f h f h"l" (136) eorgia or t e management o neurosyp i is are either benzathine 
penicilin G, 7,2 million units intramuscularly in 3 divided doses for 3 
successive weeks or aqueous procaine penicillin G, 9,0 million units intra-
muscularly in 15 daily doses of 600 000 units each. 
However there are reports of clinical failure with benzathine 
. ·11 · (57) penici in and of re-culture of the organism from the CSF after its 
d . . . 
(150) 
a ministration. A number of small studies have shown consistently that 
CSF penicillin concentrations are below the commonly accepted treponemacidal 
level after benzathine penicillin therapy.C
3S,ll3 , 125) Similarly, procaine 
penicillin G 600 000 units intramuscularly failed to provide adequate CSF 
concentration in 2 studies (a total of 5 patients).(
39 , 163 ) When combined 
with probenecid, procaine penicillin appears to achieve higher CSF 
. (39 40) concentrations. ' Intravenous aqueous pencillin Gin doses of 10-
twenty million units daily achieves consistently CSF concentrations far in 
excess of the minimum acceptable leve1.C
125 , 136 ,l63) 
Apart from the small numbers of patients, the problem with most of these 
studies is that the CSF concentrations are being measured in patients who do 
not have neurosyphilis. Thus the question whether lower doses of penicillin 
may be adequate in a setting of meningeal inflammation and disturbed blood-
brain barrier function, remains unsettled. In addition the commonly accepted 
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minimum treponemacidal penicillin concentration is extrapolated from serum 
concentrations and may well be higher than required.(Sl) 
In summary present evidence suggests that benzathine penicilin G is 
probably inadequate for neurosyphilis and aqueous penicillin G intravenously 
is certainly acceptable. The role of procaine penicillin G is not adequately 
delineated although anecdotal clinical observations suggest that it is 
effective. 
The patients in this study were treated with procaine penicillin for 10 
to 14 days. Three also received intravenous aqueous penicillin G for a few 
days. Unfortunately adequate CSF follow-up was not performed. It must be 
emphasized that the CSF should be re-examined 6 months after therapy. A 
normal or markedly reduced CSF white cell count is probably the best 
laboratory indicator of treatment effectiveness.(
76 ) 
5.4.4. Conclusions 
1. From a review of the literature, there is no clear evidence that the 
percentage of cases of neurosyphilis affecting the spinal cord has 
significantly altered since the use of penicillin. 
2. The present study suggests that the old classification of spinal 
syphilis is still valid except that it is not possible to differentiate 
between meningeal and vascular pathogeneses. 
3. The vast majority of patients with spinal cord syphilis have the 
meningovascular form of the disease but hypertrophic pacchymeningitis also 
occurs. Spinal cord gummata are exceptionally rare. 
4. The meningovascular group progress slowly over a number of weeks and 
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some are complicated by superimposed acute severe paraplegia. This latter 
event presumably represents vascular occlusion. 
is exceptionally rare but does occur. 
Slow progression over years 
5. The majority of patients with spinal cord syphilis have impaired 
position sense suggesting that syphilis has a predilection for the posterior 
columns. 
6. The majority of patients will have a raised CSF protein concentration 
and pleocytosis which is usually lymphocytic but may rarely be neutrophilic. 
The CSF glucose concentration is normal in the majority of the patients but 
can be moderately low. 
7. Laboratory criteria for the diagnosis of meningovascular syphilis have 
been proposed, with 3 categories of differing probabilities. 
8. The -majority of ~atients do not improve significantly even with adequate 
treatment, but good recoveries occasionally occur and intensive therapy 
should therefore always be administered. 
9. A literature review suggests that benzathine penicillin G is probably 
inadequate for the treatment of neurosyphilis and that intravenous benzyl 
penicillin G is undoubtedly effective. Inadequate information is available to 
assess procaine penicillin G intramuscularly but anecdotal evidence suggests 
its possible effectiveness. 
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6. MYELOPATHY ASSOCIATED WITH PULMONARY TUBERCULOSIS 
6.1. Case reports 
Four patients developed myelopathy in association with pulmonary 
tuberculosis (PTB) in the absence of tuberculous meningitis or vertebral 
tuberculosis. In view of the rarity of this condition, all 4 patients are 
described fully. 
Case No. 10 
A previously well 28 year old coloured female developed malaise, cough, 
loss of weight and night sweats in December 1983. A few weeks later she 
noticed progressive loss of vision in her left eye culminating in complete 
blindness by the end of January 1984. Thereafter v.ision began deteriorating 
in her left eye. On 7 February 1984 she was admitted .. to a peripheral 
hospital where a chest x-ray showed right upper lobe consolidation and a 
Ziel-Niehlsen stain of her sputum showed acid-fast baccili (AFB's). She was 
treated with streptomycin 1 g daily intramuscularly, pyrazinamide 2 g daily, 
isoniazid 400 mg daily and rifampicin 450 mg daily orally. 
On 13 February she developed weakness in her right leg. CSF 
examination the next day showed a protein concentration of 0,5 g/1, 2 
lymphocytes -3 and normal glucose concentration. No AFB's mm were seen. 
Prednisone 60 mg was commenced. Over the next 2 weeks the weakness in the 
right leg progressed to complete paralysis. Two days before transfer to 
Groote Schuur Hospital, weakness developed in the left leg with loss of 
sensation in both legs. This was associated with urinary retention, faecal 
incontinence and high thoracic backache. 
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On admission to Groote Schuur Hospital on 2 March she was apyrexial but 
tachypnoeic with coarse crackles audible in the right upper lobe. She was 
fully conscious and orientated. The pupils were dilated - the left was fixed 
and the right barely reactive to light. There was no perception of light in 
the left eye and only hand movements perceived on the right. 
discs were atrophic. 
Both optic 
The fifth and sixth thoracic spinous processes were extremely tender. 
There was a sensory level at T6 below which all sensory modalities were 
absent bilaterally. Abdominal reflexes were absent. There was a complete 
hypotonic areflexic paraplegia with extensor plantar reflexes. 
flaccid and a urinary catheter was in place. 
The anus was 
CSF examinations on admission showed a prot~in concentr~tion of 0,2 g/1, 
no globulin and no cells. AFB's were not seen and culture for TB bacilli was 
negative. Non-specific CSF tests for syphilis were negative. 
rays and a myelogram were normal as was an isotope bone scan. 
Spinal x-
All serum 
immunological tests for auto-immune and infective disease were negative. 
The blood leucocyte count was 14,8 x 109/t and the ESR was 87. A chest x-ray 
showed extensive active tuberculous changes in the right upper lobe and the 
left middle and lower lobes. 
Anti-tuberculosis therapy and prednisone were continued. Her course was 
complicated by severe mid-thoracic backache with pain radiating anteriorly 
bilaterally. She lost sensation in the fingers of both hands and developed 
weakness of grip bilaterally. The thoracic sensory level remained constant as 
did her visual acuity. No recovery occurred in her legs. She was 
transferred on 18 April 1984 to a peripheral TB hospital where she died. 
The cause of death is unknown as no autopsy was performed. 
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Comment 
This patient illustrates the development of bilateral optic neuropathy 
at the time of the onset of symptoms of PTB and prior to the administration 
of therapy. An acute myelopathy commenced 1 week after therapy started and 
CSF examination then showed only a minimally raised protein. There was no 
evidence of TB meningitis and a myelogram was normal. Of note was the severe 
backache with radiation. 
Case No 11. 
A previously well 20 year old coloured female developed PTB in December 
1982. She received a 6 month course of therapy with symptomatic recovery. 
In December 1983 she developed loss of weight, night sweats and haemoptysis. 
In late February 1984 she developed thoracic backache radiating anteriorly as 
a bilateral burning band. Two days later she developed bilateral leg 
weakness, worse on the left and bilateral leg numbness. She developed 
painful urinary retention needing catheterisation, but this resolved in 24 
hours. The leg weakness reached a maximum in 2 days at which stage she could 
still walk. 
About the middle of March 1984 she developed decreased vision in the 
lateral half of each visual field associated with retro-orbital pain. 
Ophthalmological examination then revealed a bitemporal hemianopia. Two days 
later she was admitted to a tuberculosis hospital where chest x-rays showed 
patchy opacification in the right lung and sputum was positive for AFB's. 
treatment was commenced with streptomycin 1 g daily, isoniazid 400 mg daily, 
rifampicin 450 mg daily and pyrazinamide 2 g daily. 
Over the next month her leg weakness improved but the severe radicular 
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pain remained. Her eyesight, 
however, continued to deteriorate to
 complete 
bilateral blindness. One mon
th after therapy commenced, her leg
s again 
weakened reaching a maximum over 
6 days. She was transferred to 
Groote 
Schuur Hospital on 19 April 1984. 
On examination she was apyrexial an
d undistressed. Chest examinat
ion 
was normal. She was fully consci
ous and alert. Both pupils wer
e fully 
dilated and reacted only sluggishly
 to light, the left more than the r
ight. 
There was no perception of light in 
the right eye and acuity in the left
 was 
limited to light perception only. 
nerves and the arms were intact. 
Fundi were normal. The remaining cr
anial 
There was increased tone in both leg
s with 
appropriate hyperreflexia and bilat
eral extensor plantar responses. 
Power 
was grade 3-5/5 on the right and 1-2
/5 on the left. There was a sensory
 
level at T6 
below which touch, pain, temperatu
re and vibration sense were 
impaired. Position sense was intact
. 
Spinal x-rays and a myelogram wer
e normal. A CT scan of brain and 
pituitary fossa was normal. CSF e
xamination on admission showed a pr
otein 
concentration of 0,2 g/1, no globul
in, no cells and normal glucose co
ncen-
tration. AFB's were not seen and cult
ure for TB bacilli was negative. 
All 
serum immunological tests for infect
ive or auto-immune disease were nega
tive. 
The blood leucocyte count was 8,0 x 
10-9/.i and the ESR 87. 
Prednisone was commenced and her ant
i-TB therapy continued. By 15 June 
the power in her right leg had retu
rned to normal and the left improved
 to 
grade 4 - 5/5. Both legs remained sp
astic. The sensory level fell to 11. 
However her severe root pain at 
T 
6 
persisted, relieved eventually by 
combination of amitryptiline and phe
nytoin. Her vision did not improve a
nd 
when last seen on 27 July she had de
veloped bilateral optic atrophy. 
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Comment 
This patient developed the 
first episode of a biphasic 
myelopathy and 
retrobulbar optic neuropathy
 some months after the onset 
of symptoms of PTB, 
prior to commencement of ther
apy. There was no evidence o
f TB meningitis and 
a myelogram and er scan were normal. 
Of note was the biphasic cou
rse of 
myelopathy with some recovery
, the optic neuropathy presen
ting as a bilateral 
hemianopia and again the sev
erity of the root pain. 
Case No. 12 
A 32 year old previously he
althy coloured female develop
ed abrupt loss 
of vision in the left eye a
ssociated with retro-orbital 
pain in May 1977. 
Vision slowly returned over 3
 days. Over the next 2 mo
nths she noticed loss 
of weight but no cough. O
n 25 June she developed bila
teral retro-orbital 
pain associated with vomiting
 and the rapid loss of vision
 in both eyes. She 
was admitted to Groote Schuu
r Hospital on 1 July. 
On examination she was py
rexial and wasted. Coarse
 crackles were 
audible in the left upper lob
e. Higher mental functions 
were normal. The 
pupils were fixed and dilated
 and fundoscopy showed bilat
eral optic atrophy. 
There was no perception of li
ght in either eye. 
Chest x-ray showed consolid
ation and cavitation in the l
eft lingula and 
AFB's were seen in the s
putum. CSF examination sh
owed a protein 
concentration of 0,3 g/1, no
 globulin, 
-3 
3 lymphocytes mm , normal 
glucose 
concentration and negative se
rologic tests for syphilis. 
No AFB's were seen 
or cultured. A er scan of the head was n









On 27 July she developed thoracic ba
ckache radiating down the right leg. 
Over a few days she developed progre
ssive weakness in both legs. 
On examination on 30 July her ey
e signs remained unchanged. The 
remainder of the cranial nerves and 
the arms were normal. She had a com
plete 
areflexic paraplegia with intermitt
ent flexor spasm and bilateral ext
ensor 
plantars. ' There was a sensory le
vel at T6 
below which touch, pain and 
temperature were reduced bilateral
ly. Vibration and position sense w
ere 
impaired in the left foot only. 
bladder. 
She had urinary retention and a dist
ended 
Spinal x-rays and a myelogram were n
ormal. Repeat CSF on 30 July showed 
a protein concentration of 0,4 g/1, 
no globulin, no cells and normal glu
cose 
concentration. The CSF IgG - album
in ratio was normal. Again bacte
rial 
studies were normal. All serum imm
unological tests were normal. 
Anti-TB therapy was continued but
 no steroids ·· used. . Her weakness
 
improved and by 17 August she had grade
 3-4/5 power in the legs. When last 
seen at the end of 1977 she was able
 to walk with much spasicity and h
ad 
recovered bladder control. Her blind
ness persisted. 
Comment 
This patient developed a bilateral 
optic neuropathy concomitantly with
 
PTB. She developed a myelopathy a fe
w weeks after commencement of treatm
ent. 
There was no evidence of TB menin
gitis and a myelogram and CT scan wer
e 
normal. The myelopathy partially re
covered but the blindness remained. 
Case No 13. 
A 41 year old black women had a 15
 year history of intermittent 
pulmonary tuberculosis. In June of 
1979 she was again found to have AFB's 
in 
her sputum and therapy with isoni
azid, pyrazinamide and ethambutol
 was 
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recommenced. In December 1979 
she developed paraesthesiae in her
 feet and 
weakness in her legs. 
static. 
The weakness progressed for 1 mont
h and then remained 
On examination 8 months later wh
en she was first seen she had no
rmal 
higher functions and cranial nerve
s. Tone and power were normal in
 her arms 
but the reflexes were symmetrica
lly brisk with bilateral positive 
Hoffman's 
signs. There was a hypertonic
 hyperreflexic paraparesis with 
extensor 
plantar responses. Power in the 
legs ranged between 2 and 4/5. 
There was 
decreased touch and vibration sens
e in the feet. 
Spinal X-rays and a myelogram wer
e normal. CSF on admission showe
d a 
protein concentration of 0,3 g/1, 
-3 
no globulin, 6 lymphocytes mm an
d normal 
glucose concentration. No AFB's
 were seen or cultured. Serologi
cal tests 
for syphilis were negative. Th
e ESR was 120. A chest X-ray 
showed 
extensive bronchiectasis with bull
ous formation. 
Anti-TB treatment was continued. H
er neurological condition · remaine
d 
static until her death in Februar
y 1984 from cor pulmonale. 
performed. 
Comment 
No autopsy was 
This patient developed a static
 mild spastic paraparesis while
 on 
treatment for PTB. 
myelography was normal. 
There was no evidence of tuberculo
sis meningitis and 
6.2. Results 
All 4 patients were female, 3 colo
ured and 1 black. The average age
 was 
26,5 years (range 18-32). 
Three of the 4 patients had neuro
myelitis optica (Devic's syndrome)
 and 
1 had myelopathy alone. Two of th
e 3 patients with Devic's synd
rome 
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commenced with optic neuropathy a
nd 1 with myelopathy. All 3 of
 these 
patients had some neurological invo
lvement before treatment was comme
nced. 
Two had already optic neuropathy an
d developed myelopathy while on treat
ment 
(1 week and 3 weeks after treatment 
commenced). The third patient de
veloped 
both optic neuropathy and myelopathy
 before she received any treatment. 
The 
fourth patient with myelopathy alone
 had been on treatment for 6 months 
when 
her paresis commenced. 
One patient (case No 10) developed
 "spinal shock" and followed an 
ascending course with arm involveme
nt. 
probably from an ascending myelopa
thy. 
She died at a peripheral hospital 
The other 2 patients with Devic's 
syndrome showed marked improvement
 in their myelopathy symptoms. On
e of 
these followed a biphasic course wi
th improvement and relapse. The 
fourth 
patient developed a mild static mye
lopathy alone. In all 3 patients 
with 
Devic's syndrome no recovery from vi
sual loss occurred.· 
A marked feature in the first 2 pat
ients was the severity of the back-
ache and root pain far out of prop
ortion to the pain experienced by 
any 
other patient in this series. So
 severe was their pain that repea
ted 
investigations for other pulmonary o
r abdominal pathology were performed
 with 
negative results. At times opioid a
nalgesics were neeeded and transcutan
eous 
nerve stimulation was used with limi
ted results. 
CSF of all 4 patients was normal exc
ept for a marginal rise in protein 
concentration (0,5 g/1 in case No 10)
 and cell count (6 lymphocytes mm-
3 in 
cases No 10 and 13). 
Steroids were used in the first






6.3.1. Clinical features 
Only 5 previous patients with ne
uromyelitis optica and PTB have 
been 
described as well as 6 others with
 myelopathy alone. 
A. Neuromyelitis Optica 
In 1956 Dickson et al(
34 ) described a patient with PTB who
 1 month after 
commencing treatment with strepto
mycin and isoniazid developed 
bilateral 
optic neuropathy. It is of in
terest that the patient's visual 
symptoms 
commenced, as in one of the prese
nt series, with a bitemporal hemia
nopia and 
progressed to complete blindness. 
Treatment was stopped for 2 weeks 
and then 
restart~d. One month later he de
veloped a severe flaccid paralegia
 with T8 
sensory level and died. Autopsy
 showed demyelination of the supe
romedial 
portion of the optic tract and ex
tensive cord necrosis but no evide
nce of TB 
in the nervous system. The m
edial distribution of the optic
 tract 
myelination may explain the initia
l hemianopia. 
illness to be due to isoniazid tox
icity. 
The authors considered the 
Soteres et al(l
4Z) described a similar patient 
on treatment with 
isoniazid who developed a severe
 myelopathy and then 4 weeks later
 a left 
optic neuropathy. The patient 
died and at autopsy marked opti
c nerve 
demyelination and extensive spinal
 cord necrosis, with at places infl
ammatory 
cell infiltrates, was found. Aga
in there was no evidence of nervou
s system 
TB. Again isoniazid was considere
d the most likely cause. 
The patient of Tommasi et al(l
49 ) developed bilateral retrobulb
ar 
neuropathy before treatment for PT
B was commenced and 2 weeks later 
developed 
a tetraparesis and died. Again
 pathology was that of inflam
matory 
demyelination · of optic nerves and 
cord. 
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The condition was first discussed comprehensively by Hughes and Mair(SO) 
who reported 1 further case. Two months after commencing treatment with 
rifampicin, isoniazid and ethambutol, the patient developed bilateral optic 
neuropathy (commencing with an homonymous hemianopia) and then 1 month later 
an ascending myelopathy from which he died. All drugs had been stopped after 
visual loss developed. Of note is the severity of the backache described, 
similar to that of 2 of the patients in the present series. Pathology was 
that of demyelination of the optic chiasms, optic nerves and tract and severe 
necrosis of the cord. 
Barbizet et al(lS) described a patient who developed acute myelopathy 
and one month later a unilateral optic neuropathy. She was found to have 
PTB. After treatment commenced the myelopathy progressed to a quadriplegia 
and optic neuropathy developed in the other eye. The myelopathy recovered 
well and by 1 year she was left with a spastic paraparesis. Vision did not 
recover. 
Thus 3 of the 5 patients were on treatment when neurological symptoms 
started. Three commenc.ed with optic neuropathy and 2 with myelopathy. This 
is similar to the sases in this series and similar to the studies of 
idiopathic Devic's syndrome, where an equal number of cases commenced with 
myelopathy and optic neuropathy.<
23 ) Including the 3 in the present series, 
6 of the 8 patients (75%) were female. Five of the 8 patients died (63%). 
B. Myelopathy alone 
Money (1960)(ll
4 ) described 3 cases of myelopathy alone in Nigerian 
blacks on isoniazid. The first patient apparently did not have active TB and 
developed a slowly progressive purely motor myelopathy over 9 months. This 
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improved once isoniazid was stopped. The second and third patients both with 
PTB and treated with isoniazid developed similar spastic parapareses with 
apparently later improvement. One of these patients also had visual 
impairment but no further details are given. The author ascribed the 
symptoms to isoniazid toxicity. Unfortunately inadequate documentation and 
lack of investigation (no myelograms were performed) makes further evaluation 
difficult. 
Hughes and Mair( 80) described 2 additional fatal cases of myelopathy 
alone. The first patient had not yet commenced treatment for PTB. His 
myelopathy partially remitted but 2 months later he developed a severe 
quadriparesis and died. The second patient had commenced treatment 5 days 
before neurological symptoms started. Path~logy in both cases showed 
extensive cord demyelination. 
Reid and Bone (1980)(l30) described a patient with spastic paraparesis 
with sensory level which developed 5 months after commencing treatment for 
PTB with ethambutol, with rifampicin, isoniazid and pyrazinamide. CSF was 
normal except for protein concentration of 0,6 g/1 and a myelogram was 
normal. Gradual improvement occurred. 
6.3.2. Differential diagnosis 
The commonest cause of myelopathy in the setting of PTB is Pott's 
disease of the spine. Other rarer possibilities are epidural, intradural 
extramedullary or intramedullary tuberculomata and arachnoiditis with 
d 
. . (97) en arteritis. The patients reported here all had normal spinal x-rays, 
normal myelograms and essentially normal CSF examinations. 
The commonest cause of optic neuropathy in this illness is TB 
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arachnoiditis with or without endarteritis affecting the optic nerve. 
I 
Alternatively basal meningitis may result in hydrocephalus causing secondary 
. l . . (115) visua impairment. The patients in this study had normal CT scans and 
the essentially normal CSF findings virtually excluded active basal 
arachnoiditis. 
6.3.3. Pathogenesis 
(a) Role of tuberculosis 
In view of how common TB is in South Africa, it must be asked whether 
the relationship of the syndrome to TB is purely coincidental. However 
although TB is common, Devic's syndrome is rare in Cape Town.CS) In the 7! 
years covered by this study, only 4 cases were identified and 3 were in the 
setting of pulmonary TB. (Devic's syndrome appears slightly commoner in the 
blacks of Natal. Cosnett( 27 ) recorded 5 patients in a 2000 bed teaching 
hospital over a 2! year period. One was found to have tuberculous adenitis 
some years after the Devic's syndrome commenced). 
In about 1/3 of cases of Devic's syndrome unassociated with PTB reported 
in the literature a non-specific viral type illness preceded the 
neurological 
varicella( 2l) 
symptoms. ( 23 ) The syndrome has been reported 
d 1 . f . (llO) an meas es in ection. Thus precedence exists 
following 
for its 
occurrence in the setting of TB. 
, 
The reported occurrence of Guillain-Barre 
syndrome in patients with TB (l54 ) is further indirect evidence that 
system demyelination can follow tuberculous infection. 
nervous 
The cord pathology in the cases described is similar to that of 
idiopathic myelopathy, ranging from extensive cord necrosis with little 
inflammation to a predominantly demyelinating process with inflammatory 




one and Barbizet et al(lS) improved markedly suggesting a partially 
reversible lesion. 
Hughes and Mair(SO) suggest that the pathogenesis is a hypersensitivity 
reaction to a myelin antigen. The tuberculous infection may have an adjuvant 
effect, non-specifically amplifying a response to minor myelin damage. 
Alternatively the TB bacillus may share antigens with myelin proteins or 
possibly mycobacteria or their degradation products might lodge in the cord 
eliciting an immune response resulting in "innocent bystander" demyelination. 
(b) Role .2f drugs 
Originally both the optic neuropathy and myelopathy were thought to be 
due to isoniazid therapy. Isoniazid cer;ainly can cause peripheral 
neuropathy and encephalopathy.C
9l) It has been considered to 0 cause optic 
( 4 92) 
neuropathy ' but only a few cases have been reported · despi.te widespread 
use of the drug and the relationship is not well documented. Myelopathy has 
1 d f d . . . . d f . . · d k Cl
32 ) resu te rom a ministering massive oses o isoniazi to moneys, but 
clinical cases are not easily provable. 
At least 2 cases in the literature(lS,l
49 ) developed the onset of 
Devic's syndrome before treatment was instituted and another patient(SO) 
progressed from optic neuropathy to myelopathy after drugs had been stopped. 
The patients in the present series provide further evidence against the role 
of drugs- all three patients with Devic's syndrome developed the onset of 
neurological symptoms before drugs were commenced and in one both myelopathy 
and optic neuropathy antedated their use. 
Thus in summary, drugs probably play little role in the pathogenesis of 
the illness and should not be discontinued if Devic's syndrome develops. 
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6.3.4. Conclusions 
1. Although PTB is extremely common in South Africa, the rarity of Devic's 
syndrome suggests that a relationship exists between the two conditions. 
2. The syndrome may commence either with myelopathy or optic neuropathy. 
3. Severe back pain and radicular pain are common. 
4. The syndrome appears to be commoner in women. 
5. The prognosis for the myelopathy is variable - in most patients it takes 
a fulminating form of progressive cord necrosis while in some it follows a 
milder course wth improvement and sometimes a remission and relapse. The 
prognosis for the optic neuropathy is very poor and the mortality rate for 
the group as a whole is high. 
6. The pathogenesis may well be a hypersensitivity reaction involving 
mycobacterium tuberculosis and is unlikely to be related to isoniazid. 
7. Myelopathy alone also occurs with PTB. While it is probably due to the 
same factors, too few cases are reported to be sure of its relationship to 
TB. 
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7. MYELOPATHY ASSCX::IATED WITH OTHER SPECIFIC INFECTIONS. 
7.1 Mycoplasma pneumoniae associated myelopathy 
There was only 1 patient in this group. 
7.1.1. Case Report (Case no 14) 
A previously well 32 year old white male developed fever and a cough. 
Seven days later he noticed he had become jaundiced. After a further 3 days 
he developed leg weakness and within 24 hours had become densely paraplegic. 
On examination, he was pyrexial with signs of consolidation over the 
left lower chest. Higher mental function and cranial nerves were normal. 
There was mild weakness (grade 4-5) in the arms but a complete flaccid 
areflexic paraplegia with a sensory level at T4 below whic
h all sensory 
modalities were absent. He had urinary retention needing _catheterisation and 
faecal incontinence. 
Chest x-ray showed a left lower lobe pneumonia. A myelogram was normal. 
CSF showed 
neutrophils 
a protein concentration of 0,5 g/1, a trace of globulin, 55 
-3 and 49 lymphocytes mm. All stains and cultures for organisms 
were negative as was syphilitic serology. There was biochemical evidence of 
a mild hepatitis. The haemoglobin concentration was 10 g/1 with a corrected 
reticulocyte count of 6%. The blood leucocyte and platelet counts were 
normal. The direct Coomb's test was positive. Mycoplasma titres in the 
serum were 1280 the day after admission (12 days after onset) and 320 two 
weeks later. The rheumatoid factor and antinuclear factor were absent, but 
circulating immune complexes were raised at 15,6% (normal O - 7%). 
The patient was managed by intubation and supportive ventilation. He 
was treated with a number of antibiotics including tetracycline. On the 9th 
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hospital day he was weaned from the ventilator. About 1 week later he had a 
single generalised seizure. A CT scan was normal and an electro-
encephalogram showed bilateral slowing. A repeat CSF examination showed a 
-3 
protein concentration of 0,5 g/1 and 4 lymphocytes.mm 
He slowly improved neurologically and 3 months after onset of symptoms 
had begun walking with assistance. 
recovery. His arms were normal. 
Follow-up three years later showed fair 
There was a sensory level at T11 be
low 
which all modalities were reduced. Both legs were spastic with 4/5 power and 
he was able to walk with crutches. He complained of urgency incontinence. 
7.1.2. Discussion 
Mycoplasma pneumoniae was first isolated in 1962.Cl
59 ) Many years 
earlier, it was recongised that some patients with primary atypical pneumonia 
had neurological complications.Cl
43 ,l53 ) Yesnick in 1956( 162 ) . reviewed the 
literature and found 38 patients with neurological manifestations of whom 9 
had cord lesions. However, in the absence of specific immunological tests, 
diagnosis was purely clinical and may have been inaccurate in many cases. 
However, since the development of easily performable complement fixation 
test, diagnosis has been simpler. A titre of greater than 128 is considered 
suggestive of recent infection,(
146) though obviously a four-fold rise in 
titre is preferable.C
24 ) However the antibodies peak early at 3 to 4 
(146) 
weeks and a four-fold fall in titre, as in the patient in the present 
. 1 b . 'f' (159) series, can a so e signi icant. 
Neurological complications well documented in the last 20 years include 
meningitis, meningo-encephalitis, acute polyradiculoneuropathyC
72 ) 
(159) 
transverse myelopathy. Less than 10 patients with acute myelopathy 
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and 
h b d d h
. . d (28,96,103,118,159) 
ave een ocumente overt is perio . In all these 
patients the myelopathy developed in a setting of pneumonia, but patients 
with meningitis and Guillain-Barre syndrome have been describedC
72 ) with 
raised mycoplasma antibodies but minimal extraneural manifestations. 
Recently doubt has been expressedC
24 ) about accepting such pure neurological 
syndromes as due to mycoplasma because of the commoness of mycoplasma 
infection in the population. It has been estimated that 2 Mycoplasma 
pneumonias occur per 1000 population per year and 30 mycoplasmal upper 
respiratory tract infection occur for each case of pneumonia. · Thus the 
possibility of isolated neurological illness being due to 
pneumoniae remains unsettled. 
Mycoplasma 
The neurological features do 
myelopathy.Cl59 ) Prognosis is variable, 
not difter from idiopathic acute 
ranging from complete recovery(l59 ) 
d . b"l" (%) to permanent isa i ity. The patient reported in the present series made 
a fair recovery. Often intracranial manifestations can accompany the 
myelopathy.( 162 ) The present patient had one seizure during recuperation. 
CSF shows a raised protein concentration with a pleocytosis either with 
( 118 159) (96) 
predominantly lymphocytes ' or neutrophils. Two patients had low 
CSF glu~ose concentrations.C96 ,l03) An associated laboratory finding of help 
is an auto-immune haemolytic anaemia with cold agglutinins.(
146 ) The present 
patient showed haemolysis with a positive Coomb's test. 
for cold agglutinins were not performed. 
Unfortunately tests 
Apart from 1 case, mycoplasmas have not been isolated from the CSF or 
nervous . 
(103) 
tissue. There is some experimental evidence for a neurotoxin 
being produced by other mycoplasmas but toxins from Mycoplasma pneumoniae 
have never been demonstrated.( 24 ) The haemolytic anaemia is due to 
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immunological cross-reactivity between the red blood cell I antigen and a 
mycoplasma glycolipid. It has been postulated that the neurological 
complications may be due to similar cross . . . h . (24) reactivity wit nervous tissue. 
With such a pathogenesis in mind, plasmapharesis has been attempted in 1 
· · h 1 1 d 1 h · h · · results.· ( 28 ) patient wit mycop asma re ate mye opat y wit unconvincing 
7.2. Epstein-Barr virus related myelopathy 
7.2.1. Results 
I have elsewhere reported the 2 patients with Epstein-Barr virus related 
myelopathies.(l3S) 
The first patient developed typical infectious mononucleosis with a 
rash, adenopathy and palatal petechiae complicated by an acute myelopathy in 
association with a cranio-spinal polyneuropathy. The evidence for the 
myelopathy was a clear truncal sensory level with early .. painless sphincter 
involvement. However in addition the patient developed areflexic weakness of 
the arms and bulbar and facial paralysis with bilateral sixth cranial nerve 
palsies. Nerve conduction studies showed severe slowing of motor conduction 
confirming a demyelinating peripheral neuropathy. 
The Paul-Bunnell test was strongly positive with a rising titre. CSF 
examination showed a protein concentration of 0,6 g/1, no globulin, 8 
lymphocytes, -3 1 neutrophil mm and a normal glucose concentration. One week 
later repeat CSF showed a protein concentration of >2 g/1, 4+globulin 16 
-3 lymphocytes and 7 neutrophils mm. Recovery was fair and 6 months after the 
illness he was able to walk without assistance. 
The second patient developed lumbar backache followed by weakness of the 
legs and urinary retention with a clear truncal sensory level for pain and 
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touch. The only manifestation of extra-neurological disease was the 
development of enlarged submandibular lymph nodes. 
The Paul-Bunnel test was negative, but antibodies to the D-component of 
Epstein-Barr virus early antigen were present to a titre of greater than 20. 
All other screens for viral agents including cytomegalovirus and hepatits B 
virus were negative. CSF examination showed a protein concentration of 0,1 
g/1, no globulin, 1 -3 lymphocyte mm and a normal glucose concentration. 
Recovery commenced after 2 days and by 10 days the only residual deficit was 
trunk weakness and a persistent sensory level. 
7.2.2. Discussion 
Between 1% and 2% of patients with infectious mononucleosis develop 
1 · 1 1 · . (17 ) Mi d' b h h d h d neuro ogica comp 1cat1ons. nor 1stur ances sue as ea aces an 
mild meningitis may be commoner, as may abnormal electroencephal.ograms.( 53 ) 
Neurological manifestations can be classified as aseptic meningitis 
(meningo-encephalitis), polyneuropathy (including Guillain-Barre Syndrome), 
mononeuropathy, monoradiculopathy and acute myelopathy. The encelphalitis can 
result in disturbances of consciousness from confusion to coma, seizures and 
focal disturbances including hemiplegia, chorea and brain-stem and cerebellar 
disorders . ( 53 ) Mononeuropathy of all 12 cranial nerves as well as the 
spinal nerves has been described.Cl34 ) 
Acute myelopathy is one of the rarest neurological complications of 
Epstein-Barr virus infections, with fewer than 20 cases in the 
l ·t t (29,43,61,117) I h 1 h . . d . h 1 era ure. n many cases t e mye opat y is associate wit a 
. h 1 · t · b · · 1 · ( 29 ) I h f · t f th 2 meningo-encep a 1 is ut can occur in 1so ation. n t e 1rs o e 




The clinical picture does not differ from idiopathic acute 
The 
. (61) concentration, 
CSF usually shows a pleocytosis with raised 
but may show raised protein alon/ 29 ) or be normal, 
one of the 2 present cases.( 138 ) 
protein 
as in 
Although the neurological complications usually follow the classic 
illness, in certain patients neurological symptoms and signs may be the 
initial, major or only clinical manifestation of the disease. The most 
common such manifestation is encephalopathy or meningo-
(49 139) , (60) encephalopathy, ' but Guillain-Barre syndrome, cranial nerve 
palsies, isolated tonic-clonic seizures and paraparesis have been 
described.Cl39 ) As specific tests of anti-Epstein-Barr virus antibody have 
been developed, so it has been realized that Epstein-Barr virus infection is 
implicated in many acute neurological illnesses in young patients and that in 
these cases heterophile antibody tests are often negative and there are 
t . . f . f 1 · · f · 1 · ( 62 ) some imes no mani estations o c assic in ectious mononuc eosis. 
The first patient described here had fever, rash, adenopathy and a 
positive Paul-Bunnell test, but the dominant feature was his neurological 
disease. The second patient had minimal systemic features and a negative 
Paul-Bunnell test but a raised titre of antibodies to the D component of 
early Epstein-Barr virus antigen, a test considered specific for new or re-
activated Epstein-Barr virus infection in the absence of lymphoma, leukaemia, 
th 1 . t 1 . t 1 · · f · ( 66) o er ma ignan esions or cy omega ovirus in ection. Ideally IgM 
antibody to viral capsid antigen should also be measured( 66 ) but this test 
was not available in Cape Town at the time the patient was admitted. These 
cases support the assertion of Silverstein et al(l39 ) that Epstein-Barr 
virus infection should be considered in any young patient with an acute 
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neurological illness. 
The prognosis of neurological complications of Epstein-Barr virus 
infection is good.( 53 ) If the patient can be supported through the acute 
illness, excellent recovery is usual. Most series report complete resolution 
of encephalitis even when decorticate rigidity is present(l34) and show a 
similar outcome for the Guillain-Barr~ syndrome. In some cases residual 
k · f 1 h but thi·s has been mi"ld.Cl39 ) wea ness remains a ter acute mye opat y, The 
first patient started to recover from almost complete paralysis on the 9th 
day of his illness and thereafter improved slowly over 9 months to almost 
full recovery. The second patient showed dramatic improvement after only 2 
days and power was normal by 7 days. 
7.3. Other infections 
Acute myelopathy has also been documented as a rare complication of 
measles, rubella, mumps, (l09 ) chicken-pox(l07) zoster( 25 ) and infection with 
herpes simplex,( 95 ) cytomegalovirus( 90) and echovirus.(SS) The pathogenesis 
of the myelopathies is not established - most are probably para - or post 
infectious hypersensitivity reactions, but some may be due to direct viral 
infection. Herpes simplex( 95 ) and echovirus(SS) have been grown from CSF in 
myelopathies and 1 autopsy study( 74 ) showed viral inclusion particles in 
spinal cord tissue and grew herpes zoster from the material. 
The clinical pictures are non-specific with the CSF usually showing a 
raised protein concentration and lymphocytic pleocytosis. Occasional cases 
with low CSF glucose concentration have been reported in cytomegalovirus( 90) 
d h . 1 (95) . f . an erpes simp ex in ections. 
Apart from viruses, acute myelopathy is reported in tetanus, (l 2) 
. k tt . l . f . (124) h" .. (20,127) . f . (157) rice sia in ection, sc istopomiasis, toxocara in ection 
d t . h" . (124) an ric inosis. 
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8. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RELATED MYELOPATHY 
8.1. Case reports 
Two patients developed myelopathy in association with probable SLE. 
Case No.15. 
A previously well 26 year old black male developed fever, nausea, 
vomiting and malaise in December 1983. 
onset of progressive leg weakness. 
This was followed by the gradual 
Two weeks later his power worsened 
markedly. He developed urinary incontinence and arm weakness and over 5 days 
became completely quadriplegic. There was no backache. 
General examination was normal. Cranial nerves were normal except for 
mild palatal weakness. There was a complete quadriplegia with general hyper-
reflexia and a left extensor plantar response. Sesnsation was lost to all 
modalities below c4 bilaterally. 
urinary catheterisation was required. 
There was an atonic anal sphincter and 
Chest X-ray, spinal X-rays and myelogram were normal. CSF on admission 
(3 days after the start of his more rapid deterioration) showed a protein 
concentration of 1 g/1, -3 2 + globulin, 6 neutrophils, 54 lymphocytes mm and 
CSF glucose concentration of 1,6 mmol/1 (29% of blood glucose concentration), 
CSF IgG albumin ratio and the IgG index( 129 ) were normal. 
cultures were negative as was syphilitic serology. 
All stains and 
Blood haemoglobin concentration and leucocyte count were normal but 
there was a persistent lymphopaenia (468 X 109 e-l and 920 X 109 e-l) before 
corticosteroid therapy. 
function was normal. 
There was no significant proteinuria and renal 
Anti-nuclear antibody titre during the patient's 
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hospital stay ranged between 20 and 500. Anti-DNA antibody levels were 
raised between 15 and 27 micrograms DNA bound per ml of serum (normal <10). 
Rheumatoid factor was negative and serum complement concentration normal. 
The patient developed respiratory difficulty necessitating tracheostomy 
and supportive ventilation. He was commenced on 60 mg Prednisone daily. Six 
weeks after admission he had regained some power in his arms, bulbar function 
was normal and ventilation was no longer required. A repeat LP three months 
after admission was normal. By the time of discharge 7 months later, he had 
only mild arm weakness but remained with a dense spastic paraplegia with a T9 
sensory level. 
Comment 
This case illustrates a severe myelopathy: in a previously well patient 
associated with persistent lymphopaenia, raised anti-nuclear factor and 
raised anti-DNA antibodies. Of note are the sudden worsening after a gradual 
start, the low CSF glucose concentration and the recovery of arm function. 
Case No. 16. 
In May 1971 a previously well 51 year old white female developed an 
illness characterized by fever, polyarthritis and bilateral pleural 
effusions. LE cells were found on 2 occasions. She was treated successfully 
with corticosteroids. 
She was then well until May 1978 when she noticed a slight weakness of 
I' 
her feet. About 7 weeks later she noticed that her right leg felt hot and 
numb and became weaker. Five days later she developed a similar sensation 
and weakness in her left leg. 
Abnormal physical findings were limited to the legs. The legs were 
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asymmetrically weak with grade 3/5 power in the left and 4+/5 power in the 
right. Both legs were hypertonic and hyperreflexic. The left plantar 
response was extensor. There was bilateral disturbance in touch, pain and 
temperature sensation, but more marked on the right. Position sense was lost 
only in the left foot. 
CSF examination showed a protein concentration of 0,1 g/1 and no cells. 
CSF IgG albumin ratio and Lange colloidal gold curve was normal and 
syphilitic serology was negative. Chest X-ray and spinal X-rays were normal 
except for mild cervical spondylosis. A myelogram was not performed as the 
patient recovered. Hb concentration and blood leucocyte count was normal. 
The rheumatoid factor, antinuclear factor, anti-DNA antibodies and tests for 
LE cells were all negative. 
Prednisone therapy was commenced. 
and sensation had markedly improved. 
Three weeks after admission, power 
By January 1979 only a burning 
sensation in the right leg remained with no objective physical signs. 
Telephonic follow-up in October 1984 revealed no further illnesses but a 
persistent dysaesthesia in the right leg. 
Comment 
This patient illustrates the development of a partial Brown-Sequard 
syndrome in a patient who 7 years earlier had a multi-system illness with 
polyarthritis, pleural effusions and positive LE cells. Of note are the slow 
onset with worsening after 7 days, a normal CSF, a negative test for auto-
immune disease during the myelopathy and excellent recovery. 
8.2. Discussion 
The reported frequency of clinical neuropsychiatric involvement in SLE 
varies between 28 and 37%,( 11 •22 •44 •) the commonest manifestations being 
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psychoses and seizures.C 44) In one autopsy study, CNS involvement was found 
pathologically in 75%( 89 ). Spinal cord diseae, however, is uncommon and 
accounts for between 1 and 7% of neuropsychiatric manifestations in large 
. (22,44,89,135) series. One smaller study of 13 patients found a 15% 
(141) frequency of myelopathy. 
Approximately 30 cases of SLE related myelopathy have been described. 
The larger series are those of Penn and Rowan (1968), (l 2l) Fulford et 
al.(1972)( 50) Adrianakos et al.(1975)( 9) and Kewalramani et al. (1979)( 93 ) 
accounting between them for a total of 16 patients. The following summary is 
based on an analysis of 27 patients in the literature described with adequate 
clinical details and the 2 patients in the present study. 
8.2.1. Clinical aspects 
The formal diagnostic criteria for SLE are laid down · in the 1982 revised 
. . f h A . Rh . A . . (145) criteria o t e merican eumatism ssociation. However, these 
criteria are designed to differentiate SLE from other collagen vascular 
disorders and thus are not always appropriate for the diagnosis of SLE as a 
cause of neurological disease. For instance only seizures and psychoses are 
permitted as neurological criteria for diagnosis and thus the myelopathy 
itself cannot be counted. Of the 27 patients in the literature, only 14 have 
the required 4 or more criteria. Both patients in the present series had 3 
criteria (lymphopaenia, raised anti-nuclear factor and raised anti-DNA 
antibodies in case 15 and polyarthritis, pleural effusions and positive LE 
cells in case No. 16). 
Myelopathy may occur as the presenting manifestation of SLE,C 50, 56 , 137 ) 
or at any stage in the disease. Case No. 15 in the present study 
illustrates the disease manifesting initially as a myelopathy. This patient 
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is of special interest because of the rarity of SLE in South African 
blacks. C1 4S) 
The duration of symptoms of myelopathy from onset to maximum varies from 
8 hoursC 93 ) to years.C 50) Seven out of 29 patients (24%) had hyper-acute 
h 1 h 12 h (64,93,121) onsets wit progression over ess tan ours and 3 others 
progressed in less than 3 days.CS) At the other end of the spectrum, all 5 
of the patients of Fulford et al( 50) progressed for longer than 6 months. Of 
interest is one patient of Hachen and Chantraine( 64) who developed a slowly 
progressive paraparesis over 6 months and then acute paraplegia over 8 hours. 
In the present series both patients progressed slowly over weeks and then 
more suddenly over days. 
The clinical picture is as variable as the time sequence. It can vary 
from a complete quadriplegiaC 94 ) to a complete paraplegia( 46) to a milder 
spastic paraparesis.C 50) In general, the more hyper-acute cases had more 
extensive signs. Sensation can vary from normal,(SO) through dissociated 
lossC 32 ,s9 , 93 ) to absence of all modalities.( 56) In a few patients cerebral 
d . 1 1 · d 1 f · ( 64 ) symptoms occurre simu taneous y e.g. seizures an ass o consciousness. 
Of special interest is that 2 of the 29 patients(l0, 94 ) developed Devic's 
syndrome and 1 other patient is alluded to in the literature without 
d 
. . (44) escription. Case No 15 in the present series developed a complete 
quadriplegia losing all sensation whereas case No 16 developed a milder 
paraparesis with a Brown-Sequard pattern. 
Only three of the 29 patients made good recoveries (including case No 16 
· h · ) ( 56 ' 137 ) T d · d · · 1 d. 6 h in t e present series . wenty i not improve inc u ing w o 
died. One patient (case No 14 in the present series) improved partially from 
a quadriplegia to a paraplegia. The remaining 5 patients (18%) followed a 
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relapsing course of partial recovery and 
d . . (64,89,121,147) . l . . (121) eterioration, one patient re apsing twice. 
secondary 
Two of these 
patients died. The time between the first and second episodes was 3-10 
months in four patients and 5 years in the fifth. In general the prognosis 
for recovery is poor - the majority of those who improve tend to relapse. 
8.2.2. Laboratory findings 
Only 1 patient (case No 15 of the present series) out of 24 whose CSF 
results are quoted, had completely normal CSF. One other patient had an 
abnormal Lange colloidal gold curve( 50) but no other abnormalaities. 
In 13 patients both CSF protein concentration and leucocyte count were 
raised, while in 9 patients protein concentration alone was raised with no 
pleocytosis. One patient 
. (89) p . concentration. rotein 
had a pleocytosis with normal CSF protein 
concentrations ranged up to 5,85. g/1 but the 
maJ·ori' ty wer:e between O 5 to 2 0 /1 The CSF's i·n all but 2 pati·ents( 46164) , , g • 
had fewer than -3 500 cells mm. CSF glucose concentration was low in 9 
patients (32%) including case No 15 of the present series. Adrianakos et 
al.( 9) suggests that this may be a fairly specific finding for SLE 
myelopathy, especially if the LP is performed on the day of onset of the 
illness. However, as discussed earlier, patients with syphilitic myelopathy 
may also rarely have low CSF glucose concentrations 
infections such as mycoplasma and cytomegalovirus. Five 
are reported with first zone Lange colloidal gold curves. 
as may some with 
t . t (46,50,56) pa ien s 
Fulford et al.C 50) described 5 patients with a more chronic myelopathy 
as an early or initial manifestation of SLE. As this resembled multiple 
sclerosis, they suggested the term "lupoid sclerosis" for the group. They 
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felt that a fairly specific laboratory picture of raised serum IgM 
concentration, abnormal serum anti-mitochondrial antibody concentration, 
negative rheumatoid factor and raised CSF protein concentration with a first 
zone Lange curve existed. This pattern has not been confirmed. 
8.2.3. Pathology 
The pathology is not uniform. The most common findings are cord 
necrosis, often haemorrhagic, involving grey and white matter, associated 
with vasculitis with thrombosis of the small arteries and veins in the 
affected area. (9,46,123) In this group small vessel vascular occlusion and 
secondary infarction appears the major pathogenetic mechanism. However, 
patients have been described with similar cord necrosis and yet normal 
(89 121) vasculature. ' One patient had a necrotic myelopathy with normal 
vessels and associated optic nerve d 1 . . (10) emye 1nat1on • ... These cases are 
similar to many of the patients with idiopathic necrotic myelopathy with 
normal vessels. Presumably an auto-immune process against myelin and neural 
tissue is responsible. 
Two cases quoted by Kewalramani et had subdural spinal 
haematomas secondarily compressing the cord, presumably due to haemostatic 
disorders. Many patients had subclinical intracerebral pathology in 
addition, usually haemorrhages or small infarcts.( 89 , 123 ) 
Another vasculitic illness that can present with acute myelopathy, often 
relapsing, is granulomatous angiitis of the nervous system. Diagnosis can be 
d ·ff· 1 d . 1 . 1 b. (30,128) 1 icu tan may require eptomeningea iopsy. Myelopathy has also 
been reported in mixed connective tissue disease.( 158 ) 
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8.2.4. Conclusions 
1. Myelopathy is an uncommon neurological manifestation of SLE. 
2. Certain patients with myelopathy and positive immunological tests for 
SLE may not have many extra-neurological manifestations especially at initial 
presentation. Others can develop myelopathy during the course of obvious 
SLE. 
3. Twenty-five percent of patients have hyper-acute onsets of myelopathy, 
suggesting a vascular pathogenesis. Other patients progress more slowly, 
some over years. 
4. Prognosis is generally poor, with at least half the patients who improve 
relapsing usually months later. The mortality rate is high (25-30%) 
5. CSF is usually abnormal with either a high protein concentration alone 
or in association with a pleocytosis. CSF glucose concentration is low in at 
least 1/3 of patients and perhaps more if LP is performed early. 
6. The pathology is usually cord necrosis due to endarteritis, but some 
patients undoubtedly have necrosis and demyelination without vasculitis 
suggesting an immunological reaction against myelin or neural tissue. 
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9. ATHEROMATOUS SPINAL CORD INFARCTION 
One patient had an obvious ischaemic myelopathy following emergency 
surgery for a ruptured aortic aneurysm. 
9.1. Case report (case no 17) 
A 52 year old white male with a background of hypertension and angina 
underwent emergency abdominal surgery on 15th November 1982. At surgery an 
aortic/common iliac artery aneurysm was found with posterior rupture. This 
was resected and the left renal vein divided. His course post-operatively 
was complicated by persistent hypotension, acute tubular necrosis and a 
myocardial infarct. 
One week after surgery he noticed he could not move his legs. 
Neurological examination revealed flaccid areflexic legs with grade 1/5 power 
in the left leg and grade 2/5 on the right. Plantar responses were not 
elicitable and the lower abdominal reflexes were absent. 
pain sensation below 11 on the right and 13 on the left. 
absent in at least the left foot. 
There was absent 
Position sense was 
One week later the signs were unchanged. He died 25 days after surgery 
in refractory shock. The spinal cord was not examined at autopsy. 
Comment 
This case represents a lumbo-sacral myelopathy following surgery for a 
ruptured aortic aneurysm followed by persistent hypotension. 
9.2. Discussion 
The rarity of atheromatous spinal cord infarcts is underlined by the 
identification of only 1 patient in this series with a definite vascular 
aetiology. 
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The blood supply of the spinal cord has already been discussed in detail 
(see section 4.3.3.). The following anatomico-pathological classification 
for spinal cord ischaemia is based on that of El-Toraei and Juler.C 4l) 
1. Aorta 
A. Dissecting aneurysms. 
Myelopathy is a rare complcation but one well documented. It is due to 
disruption and thrombosis of the origins of the segmental arteries.(?O) 
B. Surgery for abdominal aneurysms (see below for further details). 
C. Atheromatous occlusion of the origin of segmental arteries (discussed 
earlier in section 4.3.3.). 
2. Segmental arteries (intercostal and lumbar arteries). 
These can be disrupted during sympathectom/ 78 ) an~ ·o~her procedures. 
3. Radicular arteries. 
These can be occluded in the intervertebral foramina by trauma, osteo-
myelitis, tuberculous vertebral disease and neoplasms.( 4l) 
4. Vertebral artery. 
Atheroma and cervical injury including chiropractic manipulation can 
result in cord ischaemia due to vertebral artery thrombosis.C 4l) 
5. Spinal arteries. 
Although an extremely uncommon site of atheroma, the anterior and some-
times posterior spinal arteries can be involved in inflammatory processes as 
discussed earlier or by emboli. One well-documented case of a cholesterol 
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embolus to the anterior spinal artery resulting in a cord infarct has been 
described.C 99 ) 
6. Central intraspinal artery and pial arteries. 
These can be involved in inflammatory processes as discussed earlier. 
Ischaemia from all these mechanisms can be worsened by concomitant 
. (45 85) hypotension. ' 
The clinical pattern of atheromatous cord infarcts has already been 
discussed (see section 4.3.3.) 
Spinal cord ischaemia following abdominal aortic aneurysm surgery is 
well-documented but rare. Ferguson et al. reviewed 29 cases in the 
literature.C 45 ) In all cases the upper level of the myelopathy was below T
9 
and in most cases it was purely a lumbo-sacrat problem. -Twelve occurred 
after elective surgery and 17 followed emergency surgery for a ruptured 
aneurysm. 
Two groups were identified with respect to outcome - in some patients 
partial or complete recovery occurred suggesting ischaemia as the major 
mechanism, while in others the deficit was permanent suggesting cord 
infarction. Probably the pathogenesis is multifactorial with hypotension, 
resection of a a significant segmental artery and emboli to spinal arteries 
all being significant. 
followed surgery. 
In the patient reported here, prolonged hypotension 
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10. MISCELLANEOUS CAUSES 
As mentioned earlier, acute myelopathy has been associated with drugs 
and toxins (see section 4.3.3.).( 55 ,
124 ) The Japanese condition of Subacute 
Myelopathy and Optico-Neuropathy (SMON) is thought to be due to Iodoxy-
. 1· . . (124) quino ine toxicity. 
Acute necrotic myelopathy is one of the rarest of paraneoplastic 
conditions. 
excluded. 
Radiation myelopathy and secondary deposits must first be 
The condition has been described with carcinoma of the lung, 
stomach, ovary, thyroid and prostate, as well as in lymphoma (Hodgkin's and 
non-Hodgkin's types). One patient with non-Hodgkins' lymphoma developed 
1 . . t· (67,112) neuromye itis op ica. 
Sarcoid can be complicated by a chronic my.elopathy and extremely rarely 
by an acute one.Cl6) 
None of these conditions were seen in the present study. 
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11. CONCLUSION 
This study has analysed the spectrum . of acute and subacute myelopathy 
over a 7! year period as seen in a South African teaching hospital. Some 
general conclusions are formulated here. 
The first aim of the study was to analyse the spectrum of conditions 
responsible for the syndrome. A specific aetiology was found in 50% of 
cases. 
(45%). 
By far the most common was a relationship to infectious disease 
Meningo-vascular syphilis comprised half of these cases, while a 
presumed immune reaction to other systemic infections (PTB, Mycoplasma and 
Epstein-Barr virus) the remainder. The other 5% comprised vasculitic 
illnesses (SLE) and atheroma related cord infarction. All these conditions 
should be looked for in any patient presenting ~th acute cord disease. 
The second aim was to categorise the conditions clinically and to 
correlate the clinical findings with aetiology. Each aetiological group has 
been discussed separately but a few aspects are highlighted. In the 
idiopathic group the presence of partial cord syndromes and the relationship 
to brainstem disease has been more clearly delineated. The clinical picture 
of syphilitic myelopathy does not appear to have changed significantly since 
penicillin therapy became available. The relationship of PTB to Devic's 
syndrome is of considerable interest and has been discussed fully. 
The third aim was to assess the diagnostic criteria for the syndrome. 
This study has broken away from empirical criteria previously used for the 
diagnosis of "transverse myelopathy". This approach has revealed the wider 
spectrum of the condition. In each specific category diagnostic criteria are 
discussed in more detail. In particular a classification for the laboratory 
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diagnosis of meningo-vascular syphilis is proposed. 
The fourth aim was to correlate previous studies with the present one. 
Six previous studies of acute myelopathy have been reviewed, but the vast 
majority of cases discussed in these studies are idiopathic. These studies 
and others of more specific aetiological groups have been compared with the 
present one and differences and similarities analysed. 
In summary, this study has attempted to present a comprehensive clinical 
review of an important and little studied group of conditions. 
92. 
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